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resumo 
 
 
A capacidade das células dendríticas (CD) em iniciar e modular respostas 
imunes, nomeadamente a dermatite de contacto alérgica (DCA), é fortemente 
dependente da sua ativação / estado de maturação. Os mecanismos 
moleculares pelos quais os sensibilizadores de pele induzem maturação das 
CD não são ainda completamente conhecidos. No entanto, foi demonstrado 
que sinais de perigo primários como a formação de espécies reativas de 
oxigénio (ERO) desempenham um importante papel neste processo. Nos 
últimos anos, inúmeras evidências têm estabelecido uma estreita ligação entre 
a produção de ERO, stresse do retículo endoplasmático (RE) e a patogénese 
de diversas doenças inflamatórias. Deste modo, pretendeu-se no presente 
trabalho avaliar a capacidade do sensibilizador cutâneo DNFB desencadear 
stresse do RE em CD e as concomitantes consequências na imunobiologia 
dessas células. Os resultados obtidos revelaram que o DNFB induz uma 
rápida e sustentada fosforilação do fator de iniciação de tradução eucariótico 
2α (eIF2α), o aumento dos níveis proteicos do fator de transcrição ATF4 e uma 
modificação pós translacional na principal proteína chaperone do RE, GRP78. 
Verificou-se ainda que estes efeitos são dose-dependentes e parcialmente 
revertidos pelo antioxidante N-acetilcisteína, indicando que a alteração do 
estado redox celular está na origem da indução do stresse do RE observado. 
O tratamento das células com o chaperone químico, ácido 4-fenilbutírico (4-
PBA) causou um aumento na apoptose induzida por DNFB, enquanto o pré-
tratamento com salubrinal, um inibidor seletivo da desfosforilação de eIF2α, 
provocou o efeito oposto. A exacerbação pelo salubrinal da fosforilação do 
eIF2α induzida por DNFB causou um forte aumento da transcrição de genes 
de destoxificação tais como o HMOX e do gene da citoquina pró-inflamatória 
IL-8 tendo por sua vez o 4-PBA anulado completamente estes efeitos. 
Globalmente, os nossos resultados indicam que a ativação pelo DNFB do eixo 
eIF2α/ATF4 em CD contribui fortemente para o desenvolvimento de um 
microambiente pró-inflamatório e para a transcrição de genes envolvidos no 
restabelecimento do equilíbrio redox. 
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abstract 
 
The capacity of dendritic cells (DC) to initiate and modulate immune responses, 
namely allergic contact dermatitis (ACD), is tightly dependent on their 
activation/maturation state. Molecular mechanisms driving skin sensitizers-
induced DC maturation are not yet completely unrevealed, however initial 
danger signals such as the generation of reactive oxygen species (ROS) were 
shown to play an important role.  In recent years innumerous evidences 
established a close link between ROS production, endoplasmic reticulum (ER) 
stress and the pathogenesis of several inflammatory diseases. Therefore, we 
analyzed in this work the ability of the strong sensitizer DNFB to trigger ER 
stress in DC and the concomitant consequences to the immunobiology of these 
cells. Our results revealed that DNFB induces a rapid and sustained 
phosphorylation of the Eukaryotic translation initiation factor 2α (eIF2α), the up 
regulation of ATF4 and a post translational modification at the major ER 
chaperone GRP78. These effects were dose dependent and partially reverted 
by the antioxidant N-acetylcysteine, indicating that cellular redox imbalance is 
in the origin of evoked ER stress. Treatment of cells with the ER chemical 
chaperone 4 phenylbutyric acid (4-PBA) caused an increase in DNFB-induced 
apoptosis while pretreatment with salubrinal, an eIF2α dephosphorylation 
selective inhibitor, caused the opposite effect. Exacerbation of DNFB-induced 
eIF2α phosphorylation by salubrinal also caused a strong increase in the 
transcription of detoxifying genes such as HMOX and of pro-inflammatory 
cytokine IL-8 while 4-PBA completely abrogated these effects. Overall, our 
results indicate that DNFB activation of eIF2α/ATF4 stress pathways in DC 
strongly contributes to generation of a pro-inflammatory microenvironment and 
is crucial to the transcription of genes involved in remediation of cell redox 
imbalance.  
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Figure 1. Physiopathology of allergic contact dermatitis. Sensitization phase (A). 
Following an encounter with an haptenized-peptide, dendritic cells become activated, leave 
the skin, migrate via the afferent lymphatics to the draining lymph nodes and differentiate 
into fully mature DC, able to effectively present antigens to naïveT-cells. Elicitation 
phase (B). Following re-exposure of the skin to the same contact allergen, hapten-specific 
cytotoxic CD8+ T lymphocytes (CTLs) release inflammatory cytokines causing disease-
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Figure 2. Origin of different human dendritic cells subtypes. Myeloid CD34+ 
progenitors differentiate into CD14+ and CD11c+ blood precursors that then differentiate 
into immature DCs in response to granulocyte/macrophage colony-stimulating factor (GM-
CSF) and interleukin (IL)-4. In response to macrophage colony stimulating factor (M-
CSF), blood monocytic precursors originate macrophages. CD11c+ and CD14- precursors 
also yield Langerhans cells when exposed to GM-CSF, IL-4 and transforming growth 
factor (TGF) β. The CD14- CD11c- IL-3R α + DC precursor (also called pDC2, IFN α -
producing cell, or plasmacytoid T cell; a possible equivalent to the murine lymphoid DCs) 
may originate from the lymphoid CD34 + progenitor. The immature cells differentiate to 
mature cells in response to cytokines. Figure adapted from (13) .......................................... 7 
 
Figure 3. DCs phenotypic and functional changes triggered during maturation 
process. DC maturation can be triggered by multiple stimuli, including contact allergens, 
microorganisms, pro-inflammatory cytokines such as IL-1, IL-6, tumor necrosis factor-α, 
microorganisms and microorganisms components such as lipopolysaccharide (LPS), 
bacterial DNA and double-stranded RNA. The maturation process is a well-coordinated 
succession of events characterized by changes in morphology, loss of endocytic/phagocytic 
receptors, shift of chemokine receptors, resulting in acquisition of migratory capacity, up-
regulation of co-stimulatory molecules CD40, CD58, CD80, and CD86, alteration of 
secreted cytokines/chemokines and shift in lysosomal compartments. GM-CSF, 
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granulocyte–macrophage colony stimulating factor; HSP, heat shock protein; MDC, 
myeloid dendritic cell; SCF, stem cell factor; TGF, transforming growth factor. Figure 
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Figure 4. Signaling pathways triggered in dendritic cells by chemical sensitizer. The 
small chemical compound is able to covalently bind protein structures, namely lysine and 
cysteine residues, thus forming stable complexes with proteins. These complexes induce 
oxidative/electrophilic stress and consequently GSH depletion. Contact sensitizers induce 
maturation/activation of DCs by different signaling pathways. It would be reasonable that 
skin sensitisers recognized by DC as danger signals, modulate the JAK/STAT pathway. 
However, JAK/STAT signaling pathway in DCs activation by haptens is rather unlikely. 
Some sensitisers activate the NF-kB transcription factor and are probably responsible for 
some phenotypic modifications observed in DC. The most important class of MAPK 
involved in DCs activation is p38 MAPK. Activated MAPKs (p38, JNK and ERK) can 
translocates into the nucleus where they phosphorylate substrates such as transcription 
factors (Elk-1, Mef-2, Creb, c-Jun). The signalling pathway involving the repressor protein 
Keap1 (Kelch-like ECH associated protein 1) and the transcription factor nuclear factor 
erythroid 2-related factor 2 (Nrf2), which binds to the antioxidant response element (ARE) 
in the promoter region of many phase II detoxification genes is also a signalling pathway 
recently proposed. Finally, the involvement of PKC on DC migration is a prerequisite for 
skin sensitisation. Figure taken from (50) ........................................................................... 16 
 
Figure 5. Overview of Protein Trafficking Mechanisms in the ER. In the transport of 
polypeptides through the Sec61 channel, asparagines residues are often modified by 
oligosaccharyltransferase (OST) through covalent addition of an oligosaccharide core. The 
molecular chaperone BiP interacts with nascent polypeptide chains in the ER lumen, 
facilitating the unidirectional transportation through the translocon. Subsequently, 
glucosidase I and II (GlcI and GlcII) remove the two outermost glucose residues on the 
oligosaccharide core structures preparing glycoproteins for association with the calnexin 
(Cnx) and calreticulin (Crt). ERp57, an calnexin/calreticulin associated oxireductase 
facilitates protein folding by catalyzing formation of intra- and intermolecular disulfide 
bonds. The separation form calnexin/calreticulin, and the subsequent cleavage of the 
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innermost glucose residue by glucosidase II, avoids additional interactions with calnexin 
and calreticulin. In this phase, natively folded polypeptides transit the ER to the Golgi 
complex. This process is assisted by mannose-binding lectins such as ERGIC-53, VIPL, 
and ERGL. A crucial step of protein-folding control is that nonnative polypeptides are 
marked for reconnection with calnexin/calreticulin by the UDP-glucose: glycoprotein 
glucosyltransferase (UGT1). UGT1 make possible their retention in ER and avoid the 
normal transport. Misfolded polypeptides are targeted for degradation; this is perhaps 
mediated by EDEM and Derlins. COPII, coat protein complex; Triangles, glucose 
residues; squares, N acetylglucosamine residues;circles, mannose residues. Figure adapted 
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Figure 6. Signal transduction pathways of the unfolded protein response. UPR is 
controlled by the signal transducers IRE1, PERK, and ATF6 and their respective signaling 
cascades. In homeostatic conditions the chaperone protein GRP78/ BiP bind to the luminal 
domains of IRE1 and PERK preventing their dimerization. In ER stress conditions, the 
increase of unfolded proteins in the lumen of ER promotes the release of GRP78 from 
IRE1 allowing its dimerization. This dimerization stimulates IRE1 kinase and RNase 
activities leading to XBP1 mRNA splicing. Primary targets that need IRE1/XBP1 pathway 
for stimulation are genes encoding functions in ERAD. In the same way, ATF6 liberated 
from GRP78 is transported to the Golgi compartment, where it is cleaved by S1P and S2P 
proteases. The resultant fragments are then translocated to the nucleus where they act as 
potent transcriptional factors of UPR genes. Additionally, the release of, GRP78 from 
PERK allows its dimerization and activation which promotes the phosphorylation of 
eIF2α, leading to a general reduction of translational processes. Paradoxically, the eIF2α 
phosphorylation induces the translation of ATF4 mRNA, a transcription factor that 
regulates the expression of anti-oxidative stress-response genes and genes encoding 
proteins with pro-apoptotic functions, such as CHOP. Figure taken from (93) .................. 25 
 
Figure 7. Signal Transduction by IRE1. HAC1 in yest and XBP-1 in mammals are 
potent transcriptional activators of the IRE1 signaling branch of UPR.  HAC1, homologous 
to ATF/CREB 1; RPD3, reduced potassium dependency 3; HDAC, histone deacetylase 
complex;PDI1, Protein disulfide-isomerase 1; LHS1, Heat shock protein 70 homolog; 
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SCJ1, Saccharomyces cerevisiae DNAJ homolog; EDEM, ER degradation-enhancing 
alpha-mannosidase; ERAD, endoplasmic-reticulum-associated protein degradation; 
UBC7, ubiquitin conjugating enzyme 7; HRD1, HMG-CoA reductase degradation protein 
1; XBP-1, X-box binding protein. Figure adapted from (62)............................................... 27 
 
Figure 8. Signal transduction by PERK.  PERK pathway has been considered as a main 
signal transduction pathway of ER stress.  Once activated, PERK phosphorylates serine-51 
of eukaryotic initiation factor 2α (eIF2α).  When phosphorylated, eIF2α is unable to 
efficiently initiate translation, leading to inhibition of global protein synthesis. However, 
phosphorylated eIF2α also preferentially initiates translation of the ATF4 mRNA, which 
contains multiple upstream open reading frames.  Transient inhibition of translation has 
also been suggested to contribute to the cell survival role of PERK by repressing cyclin D1 
and p53 expression, which leads to cell cycle arrest.  AARE, amino acid response element; 
ARE, antioxidant response element; CHOP, CCAAT/enhance- binding protein (C/EBP) 
homologous protein; FBP,  fructose-1,6-bisphosphatase; GADD34,growth arrest and 
DNAdamage gene 34;  HERP, homocysteine-induced ER protein; NRF2, nuclear factor 
erythroid 2 (NF-E2) related factor; PEPCK, phosphoenolpyruvate carboxy-kinase; TAT,  
tyrosine amino transferase. Figure adapted from (62) ........................................................ 28 
 
Figure 9. Signal transduction by ATF6. ATF6α and ATF6β are two homolog proteins. 
When protein folding in the ER is repressed, ATF6 translocates to the Golgi complex and 
S1P, a serine protease, cleaves ATF6 in the luminal domain. The N-terminal membrane 
anchored half is cleave by the S2P. The processed forms of ATF6 α and ATF6 β 
translocates to the nucleus where they activate the transcription of target genes. Figure 
adapted from (62) ................................................................................................................ 31 
 
Figure 10. ER stress-induced apoptosis and autophagy. PERK activates its intrinsic 
kinase activity, which results in the phosphorylation of eIF2α and suppression of global 
mRNA translation. Under these conditions, only selected mRNAs, including ATF4, are 
translated. ATF4 induces expression of genes involved in restoring ER homeostasis as well 
as autophagy genes. ATF4, XBP1 and ATF6 all converge on the promoter of the gene 
encoding C/EBP homologous protein (CHOP), which transcriptionally controls expression 
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of the genes encoding BCL2-interacting mediator of cell death (BIM) and B-cell 
leukaemia/lymphoma 2 (BCL-2). Activated IRE1α recruits TRAF2 (tumor necrosis factor 
receptor-associated factor 2) to induce JNK phosphorylation and activation. The p38 
MAPK stimulates CHOP activity. JNK activates BIM, but inhibits BCL-2. Note that BCL-
2-associated X protein (BAX) and BCL-2 antagonist/killer (BAK) are also reported to 
interact with and activate IRE1α. The autophagy protein Beclin is inhibited by direct 
binding to BCL-2. Release of ATF6α permits expression of UPR and ERAD genes. In a 
general perspective unsolved ER stress activates multiple autophagy and apoptotic 
pathways. MKK, mitogen activated protein kinase kinase. Figure taken  from (85) .......... 32 
 
Figure 11. Paradoxal effects of ER stress in health and disease. The crosstalk between 
inflammation and ER stress in the pathogenesis of several diseases. ER stress-induced 
inflammation has deleterious effects on pancreatic β cells, contributing to the progression 
of type 2 diabetes. As well, ER stress causes dysfunctions in adipocytes promoting the 
progression of obesity-associated inflammation that in turn is associated with suppression 
of insulin receptor signaling observed in type 2 diabetes. Similarly, ER stress-induced 
inflammation can change intestinal epithelial cells, Paneth cells, and goblet cells, probably 
assisting the progression of inflammatory bowel diseases (IBDs) such as Crohn’s disease 
and ulcerative colitis. The progression of cystic fibrosis and cigarette smoke-induced 
chronic obstructive pulmonary disease has been also associated with ER stress-induced 
inflammation. The connection between ER stress-induced inflammation and cancer has 
dichotomous effects. Even though ER stress-induced inflammation has been publicized to 
support tumorigenesis, it has also been shown that ER stress prevents tumorigenesis by 
inducing immunogenic cell death-based antitumor immunity. Figure adapted from (84) .. 38 
 
Figure 12. Effect of DNFB on THP-1 cell viability. 0.2x10
6
 cells/well in a 96 well plate 
were exposed during 24 hours at the indicated concentrations (2 µM, 4 µM, 8 µM, 10 µM 
and 15 µM). The concentration that causes a 20% loss in cell viability (EC20)  was  
determined by linear regression. .......................................................................................... 61 
 
Figure 13. DNFB treatment induces a rapid increase in ROS levels. THP1 cells were 
loaded with the fluorogenic probe Cell ROX® Green Reagent (green) for 30 min and then 
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for visualization of F actin cytoskeleton fibers (red) and DAPI to highlight the nuclei 
(blue). Images representative of different fields were acquired with a DS-Fi2 High-
definition digital camera coupled to a Nikon fluorescent microscope (magnification 630x) 
and analyzed in NIS-Elements Imaging Software (Nikon Corporation, Japan). ................. 62 
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representative of at least three independent experiments. To ensure that equal protein 
loading between samples, the membranes were stripped, and reprobed with a β-Tubulin 
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Figure 15. Effect of DNFB (A) and Tunicamycin (B) in the mRNA levels of ER stress 
related genes. RNA was extracted after the 3h, 6h and 24h of stimulation. The relative 
expression of the genes was assessed by Quantitative Real Time-PCR. Gene expression 
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representative of at least three independent experiments and normalized using HPRT-1 and 
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Figure 17. (A) Effect of DNFB treatment on the activation of MAPK kinases. Proteins 
were extracted after 1h, 2h, 4h, 8h and 24h of stimulation and 30 µg of protein were loaded 
on a 12% SDS-polyacrylamide gel. Phosphorylated levels of JNK1/2, p38 and ERK1/2 
were assessed by Western Blot. To ensure equal protein loading between samples, the 
membranes were stripped and reprobed with total JNK1, total p38, total ERK1/2 
antibodies. The results are representative of three independent experiments. (B) 
Evaluation of the possible crosstalk between DNFB-induced MAPK activation and 
eIF2α phosphorylation. THP1 cells were pre-treated for 1h with the NAC (5 mM), 
SB203580 (15 µM), U0126 (15 µM), SP600125 (25 µM) or Salubrinal (25 µM), and then 
stimulated with 8 µM DNFB. Proteins were extracted after 1h of stimulation and 30 µg of 
protein were loaded on a 12% SDS-polyacrylamide gel. Phosphorylated levels of JNK1/2, 
p38 and eIF2α were assessed by Western Blot. The results are representative of two 
independent experiments. Equal protein loading between samples was controlled by 
stripping and reprobing membranes with total JNK1, total p38 and β-Tubulin antibodies. 
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I.Introduction 
1. Allergic Contact Dermatitis 
 
Contact dermatitis defines a group of skin inflammatory disorders caused by 
exogenous hazardous substances. There are two types of contact dermatitis: allergic 
contact dermatitis (ACD) and irritant contact dermatitis. Although both diseases may have 
similar clinical presentations, they are physiopathologicaly distinct. ACD is a cell 
mediated, delayed-type hypersensitivity reaction caused by contact of the skin with low 
molecular weight reactive chemicals (haptens) while irritant contact dermatitis is a 
nonspecific localized inflammatory reaction caused by exposure to irritants (1, 2). ACD is 
a common occupational and environmental health problem, affecting approximately 15–
20% of the general population in developed countries. This pathology is the most frequent 
work related skin disease leading to elevated economic and social costs. Metal workers, 
hairdressers, health care workers, employees in the food industry, cleaners, construction 
workers and painters are the main affected professionals (approximately 80%).  
Risk factors for allergic contact dermatitis can be subdivided into acquired and 
inherent. Acquired risk factors are generally inflammatory skin diseases such as irritant 
contact dermatitis, stasis dermatitis and possibly atopic dermatitis. In turn, inherent risk 
factors are associated with genetic variances that cause higher susceptibility.  The most 
important risk factors were identified as workplace exposure, age, gender, use of consumer 
products and genetic predispositions. Contact dermatitis occurs twice as frequently in 
women as in men and often starts at a young age, with a prevalence of 15% in 12–16 year 
olds (3). Genetic predisposition involves polymorphisms in genes that regulate xenobiotic 
metabolism, biotransformation, cellular stress responses as well as redox balance (N-
acetyltransferase, glutathione-S-transferase), inflammation, including innate and adaptive 
immunity (IL-1α, IL-1β, IL-6, IL-10, TNF-α) and skin barrier functions (4, 5).  
Polymorphisms in innate pattern recognition receptors (PRR), such as Toll-like 
receptors (TLR) and NOD-like receptors (NLR) or in cytokine receptors such as IL-12R, 
also contribute to genetic predisposition (3, 6). 
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 1.1 Physiopathology of allergic contact dermatitis 
 
Chemical-induced inflammatory responses are initially mechanistically different from 
auto-inflammation and from microbe-induced inflammation, but result in the activation of 
similar signalling pathways (6). From a pathophysiological point of view, ACD can be 
subdivided into two temporally and spatially distinct phases: the sensitization phase and 
the induction phase (Figure 1). In sensitization phase, also referred to as afferent phase, 
haptens cross the epidermis and bind covalently to proteins converting them into 
immunogenic peptides (7). Despite the great chemical heterogeneity, a common feature of 
chemical sensitizers is their intrinsic electrophilicity (with the exception of metals and 
thiols) or their potential to be metabolized to electrophilic compounds (pre and pro-
haptens) (1). There are also metals, such as nickel, which form noncovalent complexes 
with proteins and peptides. These antigenic hapten-peptide complexes are captured and 
processed by immature skin dendritic cells (DCs), including Langerhans cells and dermal 
DCs that then migrate to the paracortical region of lymph nodes. During migration, DCs 
suffer a complex and coordinated process of morphological, functional and phenotypic 
alterations designated maturation. This maturation process culminates in the acquisition of 
the capacity to prime naive T lymphocytes. In the lymph nodes, mature DCs present 
antigens to CD4 + and CD8 + T lymphocytes causing their activation and clonal expansion 
and leading to the formation of immunological memory against presented antigens. 
Specific T lymphocytes (regulatory CD4 + and effectors CD8 + T cells) leave the lymph 
nodes through the thoracic duct and circulate through the bloodstream to various tissues, 
including skin. The elicitation phase develops after the subsequent contact of the skin with 
the same hapten. The specific effector CD8 + T cells are mobilized to the induction site 
where they interact with the hapten-bearing dendritic cells, being activated. This activation 
leads to the production of cytokines (IFN-γ, GM-CSF, IL-2) and cytotoxins (perforin and 
granzyme) that cause an intense inflammatory reaction through apoptosis of keratinocytes 
and endothelial cells, activation of mast cells and recruitment and infiltration of neutrophils 
and more specific T lymphocytes. The inflammatory reaction persists for several days and 
progressively decreases through physiological regulatory mechanisms (6).  
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Figure 1. Physiopathology of allergic contact dermatitis. Sensitization phase (A). Following an encounter 
with an haptenized-peptide, dendritic cells become activated, leave the skin, migrate via the afferent 
lymphatics to the draining lymph nodes and differentiate into fully mature DC, able to effectively present 
antigens to naïveT-cells. Elicitation phase (B). Following re-exposure of the skin to the same contact 
allergen, hapten-specific cytotoxic CD8+ T lymphocytes (CTLs) release inflammatory cytokines causing 
disease-specific local skin injuries. Figure taken from (8) 
 
 The sensitization and elicitation phases of primary ACD can be induced after a 
single skin contact with haptens due to the persistence of the hapten in the skin for long 
period of time, allowing the skin recruitment and the activation of T cells which have been 
primed in the lymphoid organs (7). Although the development of contact hypersensitivity 
has been described with two spatially and temporally dissociated phases, clinical evidence 
has demonstrated that ACD could develop after a single skin contact with a strong hapten 
in previously unsensitized patients, which is referred to as “primary ACD” (9).  The 
pathophysiology of this primary (one step) ACD is identical to the classical (two step) 
ACD reaction (7).  
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2. Immunobiology and role of dendritic cells in ACD  
 
As stated in previous section, dendritic cells play a crucial role in the sensitization 
phase of ACD. These cells constitute a family of highly specialized antigen-presenting 
cells (APC) with unique abilities to prime naïve T cell. They function as sentinels, 
scanning changes in their local microenvironment and transferring the information to the 
cells of the adaptive immune system, modulating, therefore, the outcome of immune 
responses.  
 
Dendritic cells were for centuries considered part of the peripheral nervous system until 
the pioneer work of Ralph Steinman and Zanvil A. Cohn at the Rockefeller University, in 
1973 that revealed the real function of these cells. At the time, Steinman and Cohn were 
studying spleen cells to understand the induction of immune responses in a mouse major 
lymphoid organ. They were aware from research in other laboratories that the development 
of immunity by mouse spleen required both lymphocytes and "accessory cells," which 
were of uncertain identity and function. The accessory cells were thought to be typical 
macrophages, but despite extensive laboratory experience with macrophages, Steinman 
and Cohn encountered a population of cells with unusual shapes and movements that had 
not been characterized before. Because the cells had unusual tree-like or "dendritic" 
processes, Steinman named them "dendritic cells" (11). By 1992, Steinman, with critical 
input from colleagues in Europe and Japan, developed methods to generate a large number 
of dendritic cells from their progenitors. At this point, dendritic cells models were 
available for cellular and molecular biologists, and their studies have greatly expanded 
dendritic cell research (12). 
There are several subsets of DCs and their heterogeneity can be reflected by:  
- Precursor Populations: in humans, different subsets of DC precursors circulate in the 
blood (CD14+ CD11c+ CD1-, CD14- CD11c+ CD1+ and CD14- CD11c- IL 3Rα+) 
(Figure 2).  
- Anatomical Localization: these includes skin epidermal Langerhans cells (LCs), 
dermal/interstitial DCs (intDCs), splenic marginal DCs, T- zone interdigitating cells, 
germinal-center DCs, thymic DCs, liver DCs, and blood DCs. Even though certain 
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phenotypic differences have been observed among these different DC subsets, their lineage 
origins, maturation stages, and functional differences have not been evidently recognized. 
 - Function: DC subsets exert diverse functions, particularly in the regulation of B cell 
proliferation and polarization of T cells. 
- Final result of immune response: induction of immunity or tolerance (13). 
 
 
Figure 2. Origin of different human dendritic cells subtypes. Myeloid CD34+ progenitors differentiate 
into CD14+ and CD11c+ blood precursors that then differentiate into immature DCs in response to 
granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4. In response to 
macrophage colony stimulating factor (M-CSF), blood monocytic precursors originate macrophages. 
CD11c+ and CD14- precursors also yield Langerhans cells when exposed to GM-CSF, IL-4 and transforming 
growth factor (TGF) β. The CD14- CD11c- IL-3R α + DC precursor (also called pDC2, IFN α -producing 
cell, or plasmacytoid T cell; a possible equivalent to the murine lymphoid DCs) may originate from the 
lymphoid CD34 + progenitor. The immature cells differentiate to mature cells in response to cytokines. 
Figure adapted from (13) 
 The plasmacytoid dendritic cell (DC2) and its immediate precursor, the 
plasmacytoid cell (pDC2, or pre-DC2), were recently characterized in humans. Upon 
stimulation, pDC2s produce high amounts of IFN-α/β and can differentiate in vitro into 
DC2s that are capable of inducing strong T-helper cell (Th) responses (14).  
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2.1 Dendritic cell maturation process 
 
 DCs are professional antigen-presenting cells originated from CD34+ bone marrow 
progenitor cells or CD14+ monocytes. These precursors migrate through the blood into 
peripheral tissues where they differentiate into immature DCs. Immature DCs scan 
continuously their microenvironment and are extremely efficient in the uptake and 
processing of antigens. After contact with danger signals such as local inflammation or 
microbial infection, DCs maturation process is triggered.  Maturing DCs immediately 
migrate into secondary lymphoid organs where they present processed 
major histocompatibility complex (MHC)-bound peptide antigens to T-cells, thereby 
initiating antigen-specific T-cell responses (15). The maturation process is a complex and 
continuous course of events that results in morphological and phenotypical modifications 
that ultimately confers to DCs the ability to effectively stimulate T lymphocytes (2). 
Maturation of DCs can be induced by diverse danger signals such as immunoreactive 
molecules (tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), GM-CSF, T-cell 
CD40L/CD154) and bacterial/ viral products such as lipopolysaccharide (LPS), 
lipoteichoic acid, lipoarabinomannan, CpG motifs in bacterial DNA and double-stranded 
viral RNA) (13). 
  Phenotypic and functional changes associated to DCs maturation consist in several 
coordinated events such as loss of endocytic and phagocytic receptors, changes in 
morphology, modification in lysosomal compartments with down regulation of CD68 and 
up regulation of DC–lysosome-associated membrane protein (DC-LAMP) and  up 
regulation of cell surface expression of MHC II molecules (16). There is also an up 
regulation of co-stimulatory molecules necessary for lymphocyte activation, such as  the 
intercellular adhesion molecule (ICAM)-1/CD54, leukocyte functional antigen-3 (LFA)-3/ 
CD58, B7-1/CD80, B7-2/CD86, and CD83 (exclusive marker of matured DCs). During 
maturation process, cytokine expression profile is significantly changed, with a general 
increase in the expression of TNF-α, IL-10, IL-1, IL-12, IFN-γ, IL -8, IL-6, IL-23. 
Regarding chemokines, after contact with the maturation stimulus, peripheral tissue DCs 
transiently produce the inflammatory chemokines CCL2, CCL3, CCL4, CCL5, CCL8, and 
CXCL8 important for the recruitment of monocytes and neutrophils to the site of infection. 
Subsequently, in a later maturation stage, lymphoid chemokines (CCL17, CCL18, CCL19, 
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CCL22 and CXCL10) are preferentially expressed which attract T and B lymphocytes, 
facilitating this way the interaction of these cells with DCs. The expression profile of 
cytokines and chemokines is essentially conditioned by the DC subtype and the stimulus 
that triggers the maturation process  (2) (Figure 3). 
 Morphological changes that occur during DC maturation include loss of adhesive 
structures, cytoskeleton reorganization, and achievement of high cellular motility (17).  
 
 
 
  
Figure 3. DCs phenotypic and functional changes triggered during maturation process. DC maturation can be triggered 
by multiple stimuli, including contact allergens, microorganisms, pro-inflammatory cytokines such as IL-1, IL-6, tumor 
necrosis factor-α, microorganisms and microorganisms components such as lipopolysaccharide (LPS), bacterial DNA and 
double-stranded RNA. The maturation process is a well-coordinated succession of events characterized by changes in 
morphology, loss of endocytic/phagocytic receptors, shift of chemokine receptors, resulting in acquisition of migratory 
capacity, up-regulation of co-stimulatory molecules CD40, CD58, CD80, and CD86, alteration of secreted 
cytokines/chemokines and shift in lysosomal compartments. GM-CSF, granulocyte–macrophage colony stimulating factor; 
HSP, heat shock protein; MDC, myeloid dendritic cell; SCF, stem cell factor; TGF, transforming growth factor. Figure taken 
from (16). 
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2.2 Dendritic cell models 
 
The study of dendritic cells remained for a long time limited by the inability to 
isolate and purify large numbers of their different subpopulations. This problem led the 
scientific community through an intensive research process in order to establish protocols 
for in vitro differentiation of DCs. The development of such protocols revealed of great 
importance for the study of DC immunobiology. Therefore nowadays, primary DCs are 
differentiated either from human cord blood CD34+ hematopoietic precursors or peripheral 
blood CD14+ myeloid precursors. These precursors are isolated and cultivated with several 
cytokine/growth factors cocktails leading to various DC subtypes such as immature 
interstitial DCs (using GM-CSF and IL-4) or Langerhans cells (using GM-CSF, IL-4 and 
transforming growth factor-β (TGF-β) (2). However, primary DC surrogates have certain 
limitations such as difficulty in access to cell sources, time-consuming and expensive cell 
culture procedures, and more importantly, significant donor to donor variations in cell 
responsiveness. To overcome these problems of primary DCs, myeloid DC-like cell lines 
have been extensively used in the last decades. These DCs-like cell lines, although not 
completely similar in phenotype, are proven to be of great value for mechanistic and 
functional studies. In a recent work, Santegoets and collaborators have shown that 
leukemia-derived cell lines are efficient in differentiation into functional DCs, expressing 
elevated levels of co-stimulatory and MHC class I and II molecules, and are also capable 
of inducing leukemia-specific cytotoxic T cells (18). These DC surrogates created 
conditions for the improvement of highly reproducible DC vaccines and provided in vitro 
model systems for deeply studies about DC physiology. Furthermore, data provided 
demonstrate that the human CD34
+
 acute myeloid leukemic cell line MUTZ-3 shows 
functional properties that are essential for the in vivo production of CTL-mediated 
immunity and therefore represents the mainly helpful, sustainable model for myeloid DC 
differentiation and clinical DC vaccination studies (19). The most relevant characteristics 
of some common DC-like cell lines are evidenced in Table 1. In the experimental work of 
this thesis we used as DC-surrogate the human leukemic cell line THP1. This DC-cell 
model was chosen attending its easier and inexpensive maintenance in culture given that 
these cells have a rapid doubling time and do not require exogenous factors to growth. 
Furthermore THP1 cells are a good model for mechanistic studies allowing reproducible 
results when cultured for periods shorter than 2 months.   
  
11 
 
Table 1. Common DC-like cell lines such as THP-1, KG-1, HL-60, Monomac-6, U-937, K562, MUTZ-3, 
FSDC and its main characteristics. 
Cell line 
Characteristics 
THP-1 
- described for the first time in 1980; 
- human leukemia cell line; 
- individual monocytic characteristics: lysozyme production and phagocytosis ability; 
- distinct monocytic markers; 
- maintained monocytic characteristics for over 14 months; 
- obtain DC properties through stimulation with cytokines; 
- DC differentiation capabilities is very low: fewer than 5% of THP-1 cells express the classic myeloid 
DC marker CD1a following differentiation;  
- addition of calcium ionophores resulted in total differentiation and immediate maturation;  
- More similar to macrophages than to DCs; 
- express high levels of CD80, CD86, CD40, and CD83;  
- exhibit increased allogeneic T cell-stimulatory competence; 
- reduced receptor-mediated endocytosis ability  (12, 16, 17). 
 
KG-1 
- CD34+ myelomonocytic cell line; 
- derived from a patient with erythroleukemia undergoing myeloblastic degeneration (19); 
-  In culture with phorbol esters produce pseudopodia and exhibit characteristics of the 
monocyte/macrophage lineage such as phagocytic  capacities, nonspecific esterase and lysozyme-
secreting activity (20); 
-  Similarly to  THP-1 cells present low DC differentiation capacity; 
-  just about 10% of differentiated cells expressing CD1a (21–24); 
-  Differentiated cells express the DC maturation marker CD83, intermediate-to-high levels of CD86 
and HLA-DR; 
- present enhanced allogeneic T cell-stimulatory capacities; 
- maturation of the KG-1 DC was not associated with decreased antigen uptake and the acquirement of 
lymph node migration capacity (23, 25). 
 
HL-60 
- acute promyelocytic leukemia cell line; 
- competence for differentiating along the granulocytic, monocyte-macrophage, or eosinophilic 
pathway; 
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- in culture with chemicals or biological agents such as DMSO and retinoic acid, HL-60 differentiate 
into mature granulocytes (4, 26); 
- when exposed to 1, 25-dihydroxy-vitamin D3 or phorbol esters, HL-60 cells differentiated in 
monocyte-macrophage cells (27, 28); 
- when cultured in mild alkaline conditions HL-60 cells are able to differentiate into eosinophilic 
granulocytes (29); 
- limited capacity to be differentiated into DC-like cells even after cytokine exposure (30); 
- addition of calcium result in some cells differentiating into functional DCs (31); 
- unsuccessful to express MHC class II molecules; 
- low levels of MHC class I molecules (31).  
 
Monomac-6 
- human acute monocytic leukemia cell line; 
- marked monocyte phenotype; 
- present strong phagocytosis activity; 
- express NaF-sensitive nonspecific esterases and the mature monocyte marker CD14 (32); 
- in response to LPS, increase the expression of IL-1β, IL-6, and TNF-α;  
- capable of migration toward β-chemokines such as MIP-1α and -β, RANTES (19, 33, 34); 
- present characteristics similar human blood monocytes; 
- not efficient to differentiate into DC (15, 22).  
 
U-937 
- histiocytic lymphoma cell line; 
- monocytic characteristics; 
- demonstrating monoblast morphology; 
- lysozyme production; 
- esterase activity; 
- do not show phagocytic activity ( indicating that they are stopped at a relative early stage of 
monoblast maturity); 
- when stimulated with phorbol 12-myristate 13-acetate (PMA), U-937 cells mature and present  
monocytes morphologic phenotypic characteristics (35); 
- not efficient to differentiate into DC (15, 22).  
 
K562 
- chronic myelogenous leukemia cell line; 
- multipotent cell line, competent to differentiating along the megakaryocytic, erythroid, and monocytic 
pathway; 
-  develop DCs cytoplasmic projections when stimulated with PMA/TNF-α; 
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-  expression of classic DC markers such as CD86, CD40 and CD83 stays low; 
- without the presence of PMA/TNF-α the result is an exchange of the DC phenotype and function; 
- revealed to be insensitive to cytokine stimulation (36, 37); 
- protein kinase C signaling stimulate limited  DC differentiation; 
- not effective in developing DC differentiation (37). 
 
MUTZ-3 
- results from the peripheral blood of a patient with acute myelomonocytic leukemia; 
- morphological and phenotypical characteristics of monocytes: expression of monocyte specific 
esterase, myeloperoxidase enzymes, expression of monocytic marker CD14 (19); 
- requires continuous cytokine treatment  for its proliferation and survival (38); 
- when treated with GM-CSF and IL-4, present  characteristics of CD34+ derived DC precursors and to 
down regulate CD14 (22); 
-  LPS did not stimulate maturation of MUTZ-3-derived DC (most probable as an effect of reduced 
TLR4 receptor signaling and subsequent phosphorylation of p38-MAPK, ERK1, and ERK2)  (39); 
- DC differentiation capacity of MUTZ-3 cells is relatively high, reaching levels between 60 and 90% 
(18, 40); 
- closely resemble primary DCs with the exception of strong adhesion and podosome formation in the 
immature state (21, 22, 41); 
-  express intermediate-to-high levels of co-stimulatory, adhesion, and MHC class I and II molecules; 
-  exhibit a close DC phenotype; 
-  revealed to be very similar to skin LC (expressing hallmarks of the LC lineage such as Langerin, 
membrane ATPase, and CCR6) (42, 43). 
 
FSDC 
- myeloid cell line from fetal mouse skin; 
- obtained by infecting cell suspensions with a retroviral vector; 
- established by Girolomoni and co-workers in 1995; 
- exhibits a dendritic morphology; 
- its proliferation in serum-free medium was promoted by GM-CSF; 
-  expressed strong surface-membrane ATP/ADPase activity; 
-  intracellular staining for 2A1 antigen;  
- cultured in the absence of exogenous recombinant growth factors; 
- surface phenotype consistent with a myeloid precursor; 
- manifestly increased their function after treatment with GM-CSF, IL-4 or IFN-γ; 
- in vitro, pre-culture with IFN-γ was necessary for presentation of haptens to naïve T cells (44). 
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3. Molecular mechanisms of contact sensitizers-induced DC maturation 
 
 The molecular mechanisms by which sensitizers trigger and shape dendritic cell 
maturation is not yet completely unrevealed, however several evidences suggest that initial 
danger signals such generation of reactive oxygen species (ROS) and release of ATP may 
play an important role (45). ROS are significant in host defenses against bacterial 
infection, skin aging, cancer and various chronic diseases (46).  ROS are molecular oxygen 
derivatives that have a variety of functions in cells. In addition of acting as direct bacterial 
killing mechanisms, ROS also stimulate the immune response through activation of 
signaling pathways, up-regulation of surface co-stimulatory molecules, protein 
carbonylation and secretion of inflammatory cytokines such as IL-12. The processes of 
ROS production and inactivation are strongly regulated by enzymatic and non-enzymatic 
antioxidant systems (1). 
 Normal skin cells generate ROS such as superoxide anion (O2
•-
) and H2O2 as a 
result of normal metabolism. Both O2
•-
 and H2O2 may be converted to the highly reactive 
hydroxyl radical (OH
•-
) by iron (Fe
2+
)-catalyzed Haber–Weiss and Fenton reactions. ROS 
can be formed as a result of exposure to environmental agents including reactive 
chemicals. Many xenobiotics are converted to toxic quinones by the family of functionally 
related enzymes known as cytochrome P450 (CYP). These quinones are redox-sensitive 
agents and are reversibly reduced to semihydroquinones/hydroquinones, which generate 
O2
•-
. These ROS interact with lipid-rich plasma membranes and initiate a reaction known 
as lipid peroxidation. Numerous intracellular enzymes serve to degrade these reactive 
species. Some of these enzymes are specific such as superoxide dismutase (SODs), which 
dismuts O2
•-
 to H2O2, whereas others have overlapping substrate affinities such as catalase 
and glutathione peroxidases, both of which can degrade H2O2 to water and O2. Glutathione 
peroxidases also degrade organic peroxides to relatively non-toxic alcoholic species. These 
enzymes also require glutathione (GSH) during the course of peroxide degradation and 
convert GSH into its oxidized form, which is then recycled by the enzyme glutathione 
reductase (46). ROS generation may increase leak of Ca
2+
 from the ER lumen and in turn 
increases in cytosolic Ca
2+
 can stimulate mitochondrial ROS production. This results in the 
opening of permeability transition pore, leakage of GSH from the matrix and, as a 
consequence, depletion of reducing equivalents. The cellular redox homeostasis is 
  
15 
 
maintained by a dynamic interaction between reduced glutathione and protein thiols with 
ROS. Reduced glutathione GSH serves as a major thio-disulfide redox buffer in cells and 
the ratio of GSH to oxidized glutathione (GSSG) is used as an index of the redox state 
(47). 
 Dashlkhumbe Byamba and collaborators shown that contact allergens, in contrast to 
irritants, induce strong production of ROS in DC and keratinocyte cell models. In the few 
cases where irritants were shown to induce ROS, such as in benzalkonium chloride (BKC) 
treated cells, this production is not followed by DC maturation.  Additionally, they shown 
that DNCB-induced, but not BKC-induced, ROS production increased cell surface CD86 
and HLA-DR molecules on human monocyte-derived DCs (MoDCs) (1). The authors 
suggest that DNCB-induced ROS may be different from those induced by the irritant BKC 
and that this difference may partially explain the inability of irritants to mature DCs and 
trigger immune responses (1).  
The precise intracellular signal transduction pathways activated by skin sensitizers 
in DCs is not fully characterized, but several works indicate that the most common 
observation is the increase of phosphotyrosine levels and the activation of mitogen-
activated protein kinases (MAPK) in response to oxidative and electrophilic stress (48). 
Enzymes belonging to the family of MAPKs are strong candidates for activating effector 
proteins, since they propagate signals generated from different stimuli and have a 
multiplicity of signal transducing functions, converting extracellular signals into 
intracellular responses. Three major genetically distinct MAPK pathways are known at 
present in mammals: the extracellular signal-regulated kinases (ERKs), c-Jun NH2-
terminal kinases (JNKs) and 38 high osmolarity glycerol protein kinase (p38 MAPKs) (1). 
Activated MAPKs can translocate into the nucleus where they phosphorylate substrates 
such as transcription factors. Chemical sensitizers have been shown to activate the three 
MAPKs, being the increase of p38 MAPK activity the most relevant event for the DC 
maturation process (49, 50).  
 Haptens were also shown to trigger tyrosine phosphorylation and to activate 
protein kinase C (PKC), Janus kinases (JAK)/STAT pathways (Figure 4), different 
transcription factors such as NF-κB, NRF2/ARE, ATF-2, CREB, CHOP, Elk1, activating 
protein-1 (AP-1)  and to promote glutathione depletion  and changes in cell surface thiols 
(2, 50). 
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 In the next table were shown  a variety of phenotypic changes induced by various 
haptens in DCs (Table 2) (2).  
 
Figure 4. Signaling pathways triggered in dendritic cells by chemical sensitizer. The small chemical compound is 
able to covalently bind protein structures, namely lysine and cysteine residues, thus forming stable complexes with 
proteins. These complexes induce oxidative/electrophilic stress and consequently GSH depletion. Contact sensitizers 
induce maturation/activation of DCs by different signaling pathways. It would be reasonable that skin sensitisers 
recognized by DC as danger signals, modulate the JAK/STAT pathway. However, JAK/STAT signaling pathway in 
DCs activation by haptens is rather unlikely. Some sensitisers activate the NF-kB transcription factor and are probably 
responsible for some phenotypic modifications observed in DC. The most important class of MAPK involved in DCs 
activation is p38 MAPK. Activated MAPKs (p38, JNK and ERK) can translocates into the nucleus where they 
phosphorylate substrates such as transcription factors (Elk-1, Mef-2, Creb, c-Jun). The signalling pathway involving 
the repressor protein Keap1 (Kelch-like ECH associated protein 1) and the transcription factor nuclear factor erythroid 
2-related factor 2 (Nrf2), which binds to the antioxidant response element (ARE) in the promoter region of many phase 
II detoxification genes is also a signalling pathway recently proposed. Finally, the involvement of PKC on DC 
migration is a prerequisite for skin sensitisation. Figure taken from (50) 
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Table 2. The effects in different subpopulations of DCs exposed to contact sensitizers. 
Contact sensitizer Effects 
2,4-dinitrofluorobenzene (DNFB) 
1-chloro-2,4-dinitrobenzene (DNCB) 
Oxazolone 
K2Cr2O7 
2,4,6-trinitrochlorobenzene (TNCB) 
Sodium dodecyl sulfate (SDS) 
decrease in the Ia-antigen expression on Langerhans cells 
(LCs) 
interferon-α (IFN-α) 
DNCB2-mercaptobenzothiazole 
p-phenylenediamine 
ammonium tetrachloroplatinate 
internalization of MHC class II molecules on human 
monocyte cell line THP-1 
 
DNCB 
TNCB 
DNFB 
increased expression of class II MHC I-Aα on mouse LCs, 
produced of interleukin-1 (IL-1), antigen I-Aα, IL-1α, IL-1β, 
IFN-induced protein 10 (IP-10), and macrophage 
inflammatory protein 2 (MIP-2) mRNAs were up-regulated 
dinitrobenzene sulfonic acid (DNBS) 
oxazolone 
increased expression of MHC class II molecules on the XS52 
mouse bone marrow-derived cell 
trinitrobenzene sulfonic acid (TNBS) up-regulating of FcεRII (CD23), FcγRII/III (CD32/CD16) and 
CD45 
DNCB 
NiCl2 
increased the surface expression of CD54, CD86, HLA-DR 
antigen, and IL-1β production 
TNBS 
fluorescein isothiocyanate or Bandrowski`s 
base 
stimulated proliferation of autologous T lymphocytes, 
increased expression of CD83, CD86 and HLA-DR 
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NiSO4 
DNCB 
TNBS 
α-hexylcinnamaldehyde 
eugenol 
up-regulation of CD54, CD86, and HLA-DR 
TNCB increase I-A/E antigen and decrease E-cadherin expression 
 
Isoeugenol 
Cinnamaldehyde 
TNBS 
Bandrowski`s base 
p-phenylenediamine 
down-regulation of E-cadherin expression on human 
epidermal LCs as well as a significant decrease in the 
percentage of E-cadherin positive cells 
TNCB produced of type IV collagenase/ Matrix metallopeptidase 9  
(MMP-9) in LC-enriched epidermal cells 
DNCB 
DNFB 
expression of MMP-9 
NiCl2 
DNCB 
increase expression of mRNA for chemokine receptor 7 
(CCR7) 
NiCl2 increase in expression of CD54, HLA-DR, a5b1- integrin, 
CD44 and CD44v6, and directly induced the augmentation of 
CD86 expression in TGF-β1+ DCs 
DNCB 
2-mercaptobenzothiazole 
Eugenol 
p-phenylenediamine 
increased CD86 expression in THP-1 human monocyte cell 
line 
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ammonium tetrachloroplatinate 
DNCB 
DNFB 
NiCl2 
MnCl2 
down-regulation of c-fms (encoding the colony-stimulating 
factor CSF-1 receptor) 
DPCP (diphenylcyclopropene) Increase of cell-surface thiols in THP-1 
Modified proteins such as actin and β-tubulin, molecular 
chaperones, and endoplasmic reticulum stress-inducible 
proteins (51) 
 
 Despite the knowledge acquired in recent years, additional studies are required to 
completely understand cellular stress pathways elicited by skin sensitizers in DC and the 
concomitant relevance for their maturation process during the early phase of ACD. 
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4. Oxidative stress and ER dysfunction: closely linked events 
 
  Protein folding and production of ROS are closely linked events (47). Uncontrolled 
production of ROS can directly or indirectly (or both) affect ER homeostasis and 
perturbations in protein folding can cause alterations in cellular redox status and increase 
generation of mitochondrial ROS. In recent years several studies have shown a close link 
between ER stress, ROS production and the pathogenesis of metabolic and degenerative 
diseases such as type 2 Diabetes and Alzheimer and Parkinson diseases, respectively (47). 
It was shown that in Machado-Joseph syndrome, the polyglutamine repeats present in 
spinocerebrocellular atrophy protein (SCA3) form cytosolic aggregates that can inhibit the 
proteasome. Proteasome inhibition subsequently interfere with ERAD to trigger UPR 
activation, caspase 12 activation, and apoptosis (52, 53). In this model, the deletion of the 
ER stress-induced pro-apoptotic transcription factor CHOP preserved neuronal function, 
revealing the importance of UPR signaling. 
A good example of the relation between ER stress and oxidative stress was 
demonstrated by the study of Hui-Juan Gao and co-workers (54). They observed that 
alterations of the ubiquitinated proteins, valosin-containing protein (VCP) and glucose 
regulated protein 78 (GRP 78) involved in oxidative stress, UPR and proteolysis presented 
a complex and dynamic interaction at the maternal-fetal interface. In this study, they 
developed a cell model of oxidative stress using normal decidual cells to examine cell 
viability and expression levels of proteins related to endoplasmic reticulum stress and 
UPR. They found that GRP 78 and ubiquitinated proteins were significantly up-regulated 
in hydrogen peroxide (H2O2) treated cells in a dose-dependent manner. Obtained data 
allow conclude that excessive oxidative stress influence proper function of UPR by 
decreasing VCP, thereby leading to cell damage as well as inhibition of cell growth and 
activation of apoptosis. In addition, when pretreated with MG132, a pharmacological 
proteasome inhibitor, H2O2-treated decidual cells became less viable and could not up-
regulate the expression of GRP78 to resolve the protein folding defects. This indicates  that 
malfunction of UPR in decidual cells might aggravate the cytotoxic effects of ROS (54). In 
addition to the intracellular responses, chronic ER stress can also, by mechanisms that 
remain poorly characterized, cause inflammation within affected tissues. In particular, 
proteins belonging to the NOD-like receptor (NLR) family have been identified as central 
players in innate immunity (55, 56). 
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Some of these NLRs participate in multiprotein complexes termed inflammasomes, 
which mediate caspase-1-dependent maturation of the highly proinflammatory cytokine 
interleukin-1β (IL-1β). Of the thus far described inflammasomes, the NLRP3 
inflammasome is most fully characterized (57). In addition to microbial and viral PAMPs 
(pathogen-associated molecular patterns), the NLRP3 inflammasome is unique in that it 
can sense the presence of endogenous damage-associated molecular patterns (DAMPs) that 
are danger signals associated with cellular or tissue damage or stress.  In a recent work, 
Menu and collaborators demonstrated that three different compounds that are known to 
induce ER stress (BFA, Tunicamycin and thapsigargin), also activate the NLRP3 
inflammasome in human and murine macrophages (58). They showed that ER stress 
causes activation of the NLRP3 inflammasome, with subsequent release of the pro-
inflammatory cytokine interleukin-1β. This ER-triggered pro-inflammatory signal shares 
the same requirement for ROS production and potassium efflux compared with other 
known NLRP3 inflammasome activators, but is independent of the classical UPR. They 
proposed that the NLRP3 inflammasome senses and responds to ER stress downstream of 
a previously uncharacterized ER stress response signalling pathway distinct from the UPR, 
thus providing mechanistic insights to the link between ER stress and chronic 
inflammatory diseases (58). 
ASK1 is an effector of the IRE1 branch of the UPR that directly connects ER stress and 
oxidative stress. ASK1 kinase is activated in response to a variety of cytotoxic stimuli 
including TNF, Fas and ROS such as H2O2 and it is also activated by IRE1-TRAF2 
complexes in response to ER stress. Phosphorylated ASK1 subsequently activates c-Jun 
NH2-terminal kinase and p38 MAPK, being connoted with induction of programmed cell 
death. However, the roles of JNK and p38 signalling pathways during apoptosis have been 
controversial. Kei Tobiume and collaborators showed that TNF- and H2O2-induced 
sustained activations of JNK and p38 are lost in ASK1
–/–
 mouse embryonic fibroblasts, and 
that ASK1
–/– 
cells are resistant to TNF- and H2O2-induced apoptosis. TNF- but not Fas-
induced apoptosis requires ROS-dependent activation of ASK1–JNK/p38 pathways. Thus, 
ASK1 is selectively required for TNF- and oxidative stress-induced sustained activations 
of JNK/p38 and apoptosis (59). 
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Although great advances were made in last decade regarding the link between oxidative 
and ER stresses, further research is still needed to clarify their role in the genesis and 
progression of inflammatory diseases. 
5. Unfolded protein response 
 
Protein folding is a vital process in all organisms and all cells have complex 
mechanisms to avoid protein misfolding. The effectiveness of protein-folding reactions 
depends on suitable environmental, genetic, and metabolic conditions and unbalances of 
these processes present a threat to cell viability and functionality. Every protein that enters 
the secretory pathway in eukaryotic cells first enters the ER, where they fold and 
accumulate into multisubunit complexes before pass to the Golgi complex. A sensitive 
surveillance mechanism exists to prevent misfolded proteins from transiting the secretory 
pathway and ensures that persistently misfolded proteins are directed toward a degradative 
pathway. The ER-associated degradation (ERAD) allows that misfolded proteins are kept 
in the ER lumen in complex with molecular chaperones or are directed toward degradation 
through the 26S proteasome (47). 
The ER provides a unique environment that allows right protein folding as nascent 
polypeptide chains go into its lumen. The elevated concentrations of incompletely folded 
and unfolded proteins present on ER lumen tend to increase aggregation phenomena. 
Therefore, this organelle process high level of polypeptide-binding proteins, such as 
GRP78/BiP and GRP94 that works to slow protein-folding reactions and prevent abnormal 
interactions and aggregation. The ER lumen also needs to be an oxidizing environment in 
order to allow the formation of disulfide bonds. As a result, cells express many protein 
disulfide isomerases (PDIs) that guarantee correct disulfide-bond formation and avoid 
creation of wrong disulfide bonds. Additionally, ER is the primary intracellular 
Ca
2+
 storage/release organelle. Calcium is a crucial second messenger in numerous 
intracellular signalling processes and the control of its cytosolic free levels is of extreme 
importance for the correct functioning of the cell. Protein-folding reactions and protein 
chaperone functions need elevated ER intraluminal Ca
2+
 levels. The protein folding 
process also requires extensive quantities of energy (ATP) for chaperone function, to 
preserve Ca
2+
 stores, the redox homeostasis and for ERAD (47, 60). Once in the ER lumen, 
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proteins may suffer several posttranslational modifications such as N-linked glycosylation, 
amino acid modifications such as proline and aspartic acid hydroxylation and γ-
carboxylation of glutamic acid residues, and addition of glycosylphosphatidylinositol 
anchors. N-linked glycosylation is an extremely regulated process closely related to 
chaperone interactions which ensures that only correctly folded proteins exit the ER 
compartment. These processes are highly sensitive to disturbances of the ER luminal 
environment and are therefore affected by many environmental threats. Such insults 
include mechanisms that induce depletion of ER Ca
2+
, alterations in the redox status and 
deprivation of energy (sugar/glucose) (47). Additionally, gene mutations, overload of ER 
compartment with newly synthesized proteins and disrupted posttranslational modification 
also contribute to the accumulation of unfolded proteins in the ER lumen (Figure 5). 
 
Figure 5. Overview of Protein Trafficking Mechanisms in the ER. In the transport of polypeptides 
through the Sec61 channel, asparagines residues are often modified by oligosaccharyltransferase (OST) 
through covalent addition of an oligosaccharide core. The molecular chaperone BiP interacts with nascent 
polypeptide chains in the ER lumen, facilitating the unidirectional transportation through the translocon. 
Subsequently, glucosidase I and II (GlcI and GlcII) remove the two outermost glucose residues on the 
oligosaccharide core structures preparing glycoproteins for association with the calnexin (Cnx) and 
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calreticulin (Crt). ERp57, an calnexin/calreticulin associated oxireductase facilitates protein folding by 
catalyzing formation of intra- and intermolecular disulfide bonds. The separation form calnexin/calreticulin, 
and the subsequent cleavage of the innermost glucose residue by glucosidase II, avoids additional 
interactions with calnexin and calreticulin. In this phase, natively folded polypeptides transit the ER to the 
Golgi complex. This process is assisted by mannose-binding lectins such as ERGIC-53, VIPL, and ERGL. A 
crucial step of protein-folding control is that nonnative polypeptides are marked for reconnection with 
calnexin/calreticulin by the UDP-glucose: glycoprotein glucosyltransferase (UGT1). UGT1 make possible 
their retention in ER and avoid the normal transport. Misfolded polypeptides are targeted for degradation; 
this is perhaps mediated by EDEM and Derlins. COPII, coat protein complex; Triangles, glucose residues; 
squares, N acetylglucosamine residues;circles, mannose residues. Figure adapted from  (47) 
Proper adjustment to misfolded protein accumulation requires modifications at multiple 
levels including transcription, translation, translocation into the ER lumen, and 
endoplasmic-reticulum-associated protein degradation (ERAD). The inability of cell to 
resolve incorrect protein folding processes leads to a sustained activation of the UPR 
signalling, which has been shown to induce  apoptotic responses (61–64). 
Intensive research in last decade revealed  diverse mechanisms of the UPR signalling 
pathway being established that the response to ER stress is leaded  by three transmembrane 
signal transducers: the kinases inositol-requiring kinase 1 (IRE1) and PERK (double-
stranded RNA-activated protein kinase-like ER kinase) and the activating transcription 
factor 6 (ATF6) (Figure 6). 
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Figure 6. Signal transduction pathways of the unfolded protein response. UPR is controlled by the signal transducers 
IRE1, PERK, and ATF6 and their respective signaling cascades. In homeostatic conditions the chaperone protein GRP78/ 
BiP bind to the luminal domains of IRE1 and PERK preventing their dimerization. In ER stress conditions, the increase of 
unfolded proteins in the lumen of ER promotes the release of GRP78 from IRE1 allowing its dimerization. This 
dimerization stimulates IRE1 kinase and RNase activities leading to XBP1 mRNA splicing. Primary targets that need 
IRE1/XBP1 pathway for stimulation are genes encoding functions in ERAD. In the same way, ATF6 liberated from 
GRP78 is transported to the Golgi compartment, where it is cleaved by S1P and S2P proteases. The resultant fragments are 
then translocated to the nucleus where they act as potent transcriptional factors of UPR genes. Additionally, the release of, 
GRP78 from PERK allows its dimerization and activation which promotes the phosphorylation of eIF2α, leading to a 
general reduction of translational processes. Paradoxically, the eIF2α phosphorylation induces the translation of ATF4 
mRNA, a transcription factor that regulates the expression of anti-oxidative stress-response genes and genes encoding 
proteins with pro-apoptotic functions, such as CHOP. Figure taken from (93) 
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5.1 IRE1 signalling 
 
In the early 1990s, by a genetic screen approach,  two different groups identified 
IRE1p/Ern1p as an ER transmembrane protein kinase that operates as a proximal sensor in 
the yeast UPR (65). IRE1p is a bi-functional protein that also presents a site-specific 
endoribonuclease (RNase) activity (66). In homeostatic conditions, IRE1p protein kinase is 
kept in an inactive form through interactions with the protein chaperone BiP. However, 
under ER stress, IRE1p is released from BiP and go through homodimerization and trans-
autophosphorylation which leads to activation of its RNase activity. The RNase activity of 
IRE1p causes the cleavage of a 252-base intron from mRNA encoding the basic leucine 
zipper (bZIP)-containing transcription factor HAC1p. Subsequently, the protein encoded 
by spliced HAC1 (homologous to ATF/CREB 1) mRNA attach and activates the 
transcription of many UPR target genes (63, 67). 
IRE1α and IRE1β have been identified as two mammalian homologues of yeast 
IRE1 (68). IRE1α is ubiquitously expressed in cells and tissues, being high levels found in 
pancreas and placenta. In turn, IRE1β is predominantly expressed in intestinal epithelial 
cells. These two proteins present similar cleavage specificities, suggesting that they do not 
recognize distinct substrates but rather have temporal and tissue specific expression (69, 
70). In mammals, the functional homolog of HAC1p is XBP-1 (X-box binding protein) 
mRNA, being the substrate for the endoribonuclease activity of IRE1α/IRE1 β (62, 71). 
Under ER stress, IRE1 RNase activity is triggered resulting in the removal of a 26-
nucleotide intron from XBP1 mRNA. This splicing process results in the translation of a 
larger form of XBP1 that exhibits a new transcriptional activation domain in its C-
terminus. Spliced XBP1 is a potent transcriptional activator of numerous genes involved in 
UPR such as the ones involved in ERAD (Figure 7). This fact was demonstrated by 
experiments in which  cells lacking  IRE1 or XBP1 are unable to execute ERAD (72). 
Furthermore, IRE1 and XBP1 have shown to play crucial roles in B-cell differentiation 
(73, 74). Upon antigenic stimulation, UPR is activated in B lymphocytes and IRE1-
mediated XBP1 mRNA splicing is required to B-lymphocyte differentiation into plasma 
cells (74). These data suggest that the IRE1/XBP1 signalling pathway may be necessary 
for differentiation of cell types that secrete elevated levels of protein (73). 
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In addition to its endoribonuclease activity over XBP1 mRNA, IRE1 phosphorylation 
activates the MAP kinase signalling cascade. The IRE1 cytoplasmic domain interacts with 
the adaptor protein tumor necrosis factor receptor–associated factor 2 (TRAF2). IRE1 and 
TRAF2 interact with the mitogen activated protein kinase apoptosis signal-regulating 
kinase 1 (ASK1) which subsequently phosphorylates and activates JNK (59, 63, 75).  
 
  
Figure 7. Signal Transduction by IRE1. HAC1 in yest and XBP-1 in mammals are potent 
transcriptional activators of the IRE1 signaling branch of UPR.  HAC1, homologous to ATF/CREB 1; 
RPD3, reduced potassium dependency 3; HDAC, histone deacetylase complex;PDI1, Protein disulfide-
isomerase 1; LHS1, Heat shock protein 70 homolog; SCJ1, Saccharomyces cerevisiae DNAJ homolog; 
EDEM, ER degradation-enhancing alpha-mannosidase; ERAD, endoplasmic-reticulum-associated 
protein degradation; UBC7, ubiquitin conjugating enzyme 7; HRD1, HMG-CoA reductase degradation 
protein 1; XBP-1, X-box binding protein. Figure adapted from (62) 
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5.2 PERK signalling 
 
 Activation of PERK has two major consequences: phosphorylation of the α subunit 
of eukaryotic translation initiation factor 2 (eIF2α) and phosphorylation of the nuclear 
factor erythroid 2 (NF-E2) related factor (Nrf2) (Figure 8) (62).   
 
 
 
 
 
 
 
 
 
Figure 8. Signal transduction by PERK.  PERK pathway has been considered as a main signal transduction 
pathway of ER stress.  Once activated, PERK phosphorylates serine-51 of eukaryotic initiation factor 2α (eIF2α).  
When phosphorylated, eIF2α is unable to efficiently initiate translation, leading to inhibition of global protein 
synthesis. However, phosphorylated eIF2α also preferentially initiates translation of the ATF4 mRNA, which 
contains multiple upstream open reading frames.  Transient inhibition of translation has also been suggested to 
contribute to the cell survival role of PERK by repressing cyclin D1 and p53 expression, which leads to cell cycle 
arrest.  AARE, amino acid response element; ARE, antioxidant response element; CHOP, CCAAT/enhance- 
binding protein (C/EBP) homologous protein; FBP,  fructose-1,6-bisphosphatase; GADD34,growth arrest and 
DNAdamage gene 34;  HERP, homocysteine-induced ER protein; NRF2, nuclear factor erythroid 2 (NF-E2) 
related factor; PEPCK, phosphoenolpyruvate carboxy-kinase; TAT,  tyrosine amino transferase. Figure adapted 
from (62) 
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 In response to the accumulation of unfolded proteins, a rapid translation attenuation 
of mRNA occurs in order to prevent the influx of newly synthesized polypeptides into the 
stressed ER. This translation attenuation is mainly due to PERK-mediated phosphorylation 
of the eukaryotic translation initiation factor 2 into the α subunit (eIF2α).  The eIF2α is part 
of the heterotrimeric complex eIF2, which in a GTP-bound form that binds methionyl-
initiator tRNA (Met-tRNAi
Met
). The eIF2-GTP-Met-tRNAi
Met
 complex is required for 
AUG initiation codon recognition and association with the 60S ribosomal subunit that 
occurs during initiation phase of polypeptide chain synthesis. Phosphorylation of eIF2α 
inhibits exchange of GDP for GTP in eIF2 and decreases the concentration of the complex. 
Additionally, phosphorylation of eIF2α activates translation of mRNAs encoding 
numerous short upstream open reading frames (uORFs) (76). At low levels of eIF2α 
phosphorylation, uORFs are efficiently translated, resulting in repression of translation of 
the downstream ORF. When phosphorylation of eIF2α is high, the small ribosomal subunit 
scans through several uORFs before being loaded again with the ternary eIF2-GTPMet-
tRNAi
Met
 complex, which then allows for translation of the downstream ORF (62). 
Although PERK-mediated phosphorylation of eIF2α inhibits the translational processes in 
general, it selectively activates the translation of  one essential transcription factor of the 
UPR: the activating transcription factor 4 (ATF4) (47, 77). ATF4 is a transcription factor 
that induces the expression of genes involved in amino acid metabolism, antioxidant 
response and apoptosis, such as the DNA damage 34 (GADD34) and the Growth arrest and 
DNA damage-inducible protein (GADD153)/ CHOP (77).  
In addition to the PERK-eIF2α signaling cascade, several studies proposed that 
nuclear factor erythroid 2 (NF-E2) related factor (Nrf2) may also be a substrate for the 
PERK kinase activity (78). In unstressed cells, Nrf2 is found in an inactive cytoplasmic 
complex with the cytoskeletal anchor Kelch-like Ech-associated protein1 (Keap1). In ER 
stress conditions, PERK phosphorylates Nrf2, resulting in dissociation of the Nrf2-Keap1 
complex, translocation of Nrf2 to the nucleus where it binds to the antioxidant response 
element (ARE) activating the transcription of genes encoding detoxifying enzymes (78). 
Genes regulated by ARE include the A1 and A2 subunits of glutathione S-transferase, 
NAD(P)H: quinone oxidoreductase, γ-glutamylcysteine synthetase, heme oxygenase 1, and 
UDP-glucuronosyl transferase (79).  
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 A growing body of data suggests that PERK phosphorylates multiple substrates to 
protect cells from oxidative stress (80). Consistent with this observations, perk−/− cells 
accumulated ROS when exposed to ER stress (81). Thus, the sensitivity of nrf2−/− cells to 
ER stress results from their impaired ability to respond to an oxidative insult. The notion 
that an imbalance in the cell’s redox status is caused by ER stress is further supported by 
the observation that the redox sensitive transcription factor NF-κB is activated in response 
to ER stress and that this activation was inhibited by antioxidants. NF-κB is one of the 
central effectors of innate and inflammatory responses. Although, all three UPR branches 
can activate NF-κB, they use different mechanisms. Generally, NF-κB is kept in an 
inactive form within the cytoplasm by the IκB proteins, which prevent its activation and 
nuclear translocation (47, 62).  
 
 
5.3 ATF6 signaling 
 
The bZIP-containing activating transcription factor 6 (ATF6) was recognized as an 
additional regulatory protein that, like XBP1, binds to the ER stress-response element 1 
(ERSE1) in the promoters of UPR-responsive genes. ATF6 has two alleles, ATF6 α 
(90kDa) and ATF6 β (110 kDa) that are equally found in all cell types as ER 
transmembrane proteins. ATF6 is located at the ER membrane and bounds to BiP in 
homeostatic conditions. Under ER stress conditions, BiP dissociation allows the transport 
of ATF6 to the Golgi complex, where it is successively cleaved by the serine protease site-
1 protease (S1P) and by the metalloprotease site-2 protease (S2P). The processed forms of 
ATF6 α and ATF6 β translocate to the nucleus and bind to the ATF/cAMP response 
element (CRE) and to the ERSE1 to stimulate the transcription of target genes. The 
proteases S1P and S2P were first known for their important function in processing of the 
sterol response element binding protein (SREBP), a transcription factor that is activated on 
cholesterol deprivation (Figure 9) (71, 82, 83). 
In addition to ATF6, CREBH an extra bZIP-containing transcription factor of the 
CREB/ATF family was recently identified in the ER. The transcription of CREBH is 
augmented by pro-inflammatory cytokines IL-6, 1L-1β, and TNFα. During ER stress, 
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CREBH transits to the Golgi compartment, here it is cleaved by S1P and S2P enzymes. 
While cleaved CREBH does not start transcription of UPR genes, it induces transcription 
of many acute-phase response genes, such as C-reactive protein and murine serum amyloid 
P component (SAP) in hepatocytes. CREBH has been shown to be a crucial transcription 
factor in initiation of innate immune response and in the  connection of the ER stress to 
inflammatory responses (47, 62, 84).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Signal transduction by ATF6. ATF6α and ATF6β are two homolog proteins. When 
protein folding in the ER is repressed, ATF6 translocates to the Golgi complex and S1P, a serine 
protease, cleaves ATF6 in the luminal domain. The N-terminal membrane anchored half is cleave 
by the S2P. The processed forms of ATF6 α and ATF6 β translocates to the nucleus where they 
activate the transcription of target genes. Figure adapted from (62) 
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6. ER Stress-Induced Apoptosis and Autophagy 
 
 The UPR is tailored essentially to re-establish ER homeostasis also through 
adaptive mechanisms involving the stimulation of autophagy (85). However, when 
persistent, ER stress can switch the cytoprotective functions of UPR and autophagy into 
cell death promoting mechanisms (86). If the UPR sensors fail to correct the accumulation 
of unfolded protein, both autophagy and cell death pathways are triggered (Figure 10). The 
ER may actually be viewed as a local where apoptotic signals are produced and integrated 
to trigger death responses (64).  
Figure 10. ER stress-induced apoptosis and autophagy. PERK activates its intrinsic kinase activity, 
which results in the phosphorylation of eIF2α and suppression of global mRNA translation. Under these 
conditions, only selected mRNAs, including ATF4, are translated. ATF4 induces expression of genes 
involved in restoring ER homeostasis as well as autophagy genes. ATF4, XBP1 and ATF6 all converge on 
the promoter of the gene encoding C/EBP homologous protein (CHOP), which transcriptionally controls 
expression of the genes encoding BCL2-interacting mediator of cell death (BIM) and B-cell 
leukaemia/lymphoma 2 (BCL-2). Activated IRE1α recruits TRAF2 (tumor necrosis factor receptor-
associated factor 2) to induce JNK phosphorylation and activation. The p38 MAPK stimulates CHOP 
activity. JNK activates BIM, but inhibits BCL-2. Note that BCL-2-associated X protein (BAX) and BCL-2 
antagonist/killer (BAK) are also reported to interact with and activate IRE1α. The autophagy protein Beclin 
is inhibited by direct binding to BCL-2. Release of ATF6α permits expression of UPR and ERAD genes. In 
a general perspective unsolved ER stress activates multiple autophagy and apoptotic pathways. MKK, 
mitogen activated protein kinase kinase. Figure taken  from (85) 
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ER-dependent apoptosis may be triggered by several mechanisms such as PERK/eIF2α 
dependent induction of the pro-apoptotic transcription factor CHOP; BCL-2-associated X 
protein (BAX)/ BCL-2 antagonist/killer (BAK) regulated Ca
2+
 release from the ER; IRE1 
mediated activation of ASK1/JNK;  Cleavage and activation of pro-caspase 12 (47). ER 
stress is also able to promote ROS formation and mitochondrial ROS can as well be 
formatted as a result of ER stress–induced Ca2+ release and consequent depolarization of 
the internal mitochondrial membrane (47). Probably the most significant ER stress-induced 
apoptotic pathway is mediated through CHOP. CHOP/GADD153 (growth arrest and DNA 
damage gene 153) is a bZiP transcription factor that is induced through the PERK, IRE1 
and ATF6 UPR branches (87, 88). Although the precise mechanism by which CHOP 
mediates apoptosis is unknown, several studies demonstrated that it activates the 
transcription of several genes that potentiate apoptosis. These include GADD34 (growth 
arrest and DNA damage gene 34), ERO1 (Endoplasmic oxidoreductin-1), DR5 (death 
receptor 5), TRB3 (Tribbles homolog 3). GADD34 encodes a subunit of protein 
phosphatase 2C that enhances dephosphorylation of eIF2α and promotes protein synthesis 
(89). ERO1 encodes an ER oxidase that increases the oxidizing potential of the ER (90). 
DR5 encodes a cell-surface death receptor that may activate caspase cascades (91). TRB3 
encodes a human orthologue of Drosophila tribble, and Trb3-knockdown cells are resistant 
to ER stress-induced apoptosis (47, 92). CHOP has also been implicated in repressing the 
transcription of the anti-apoptotic BCL2 protein, which leads to enhanced oxidant injury 
and apoptosis. During ER stress, pro-apoptotic members of the BCL2 family are recruited 
to the ER surface and activate caspase-12. In contrast, the anti-apoptotic members prevent 
this recruitment, although the exact relation between these factors is still unclear. The over 
expression of BCL2 family members can prevent ER stress-induced apoptosis (93). BH3 
domain (BCL2-homology domain 3)-only containing pro-apoptotic factors, such as BAX 
and BAK, are present at the mitochondrial and ER membranes (93). Under ER stress 
conditions, BAX and BAK oligomerize, allowing Ca
2+
 efflux into the cytoplasm where at 
milimolar concentrations it activates dependent and -independent caspase signaling 
cascades (94). Additionally, BH3 domain only family members, p53 up-regulated 
modulator of apoptosis (PUMA) and neutrophil NADPH oxidase factor (NOXA), are up-
regulated by p53 during ER stress and are also involved in programmed cell death 
signaling cascades  (47, 64).  
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IRE1 branch of the UPR also directly relates with cell death and survival. IRE 1 
phosphorylation activates the MAP kinase signalling cascade. The IRE1 cytoplasmic 
domain interacts with the adaptor protein tumor necrosis factor receptor–associated factor 
2 (TRAF2) that in turn interacts with the mitogen activated protein kinase, ASK1 which 
subsequently phosphorylates and activates JNK leading to apoptosis (59, 63, 75). TRAF2 
is involved in other mechanisms that control programmed cell death such as the association 
with and activation of caspase-12 and the activation  of the transcriptional repressor ATF3 
leading to apoptosis. UPR activation of IRE1 may also initiate the extrinsic apoptotic 
pathway. IRE1 interacts with tumor necrosis factor receptor 1 (TNFR1) to form a complex 
with TRAF2 and ASK1 to mediate JNK activation. Furthermore, the expression of TNF-α 
is up-regulated by the IRE1 pathway during ER stress. ROS can directly activate ASK1 by 
disrupting an ASK1-thioredoxin (TDX) complex through oxidation of TDX, and thereby 
lead to activation of JNK, p38 MAP kinase, and cell death. The Jun activation domain-
binding protein (JAB1) may be a feedback regulator because it can interact with IRE1 and 
inhibit XBP1 mRNA splicing and BiP transcription. Thus, oxidative stress and ER stress 
may induce cell death using the same molecular complex consisting of 
IRE1/TRAF2/ASK1/TDX  (64, 95). TNF-α was also shown to activate the UPR in a ROS-
dependent manner indicating that an intricate relation exists between death-receptor 
signalling, oxidative stress, and activation of the UPR (45, 51). 
 Recent studies showed that the Selenoprotein S (SEPS1), an ER resident protein 
related to production of inflammatory cytokines, may play an important role in the control 
of ER stress-mediated apoptotic processes (96). The over expression of SEPS1 in 
macrophages showed to have a protective effect against ER stress-induced cytotoxicity and 
apoptosis (96). The protective action of SEPS1 is largely dependent on ER stress-mediated 
cell death signal with less effect on non-ER stress component cell death signals. 
Conversely, suppression of SEPS1 resulted in sensitization of macrophages to ER stress-
induced cell death (96). 
 
 
 
 
  
35 
 
 In order to clear the ER from the accumulation of terminally misfolded protein 
aggregates that cannot be degraded by the proteasome, the UPR may activate also the 
autophagy machinery. Proteasomal degradation and autophagy are the two main 
mechanisms that are in charge of protein clearance in the cell (97). In spite of its role as a 
self-digestion mechanism, autophagy is mainly activated to protect against cell death. 
Through the autophagic process, complete cytoplasmic portions, including organelles and 
other cytoplasmic components are “swallow up” by double membrane vesicle designated 
autophagosomes (98). The maturation of these vesicles involves their fusion with 
lysosomes, which leads in turn to the degradation of the autophagosome components by 
the lysosomal degradative enzymes (99). A variety of stress signals such as nutrient 
starvation or treatment with different agents that induce ER stress (DTT, Tunicamycin, 
Thapsigargin, or proteasome inhibitors) stimulate the autophagy process (100–105). Also, 
autophagy can facilitate cells to survive with ER stress or participate in the mechanism of 
ER stress- induced cell death (86).  
 The molecular pathway that is responsible for the initiation of autophagy after ER 
stress is not completely established Maiko Ogata and co-workers suggested an 
involvement of IRE1 signalling via JNK-1 but not XBP1, and independent of PERK1 and 
ATF6 (103). Moreover, the phosphorylation of Beclin 1 by JNK-1 is essential for the 
induction of autophagy under starvation conditions (106). IRE1 interact also with TRAF-2 
and activates JNK (103).  JNK has been proposed to regulate autophagy through BCL-2 
phosphorylation, which prevents this protein of interacting (and inhibiting) the essential 
autophagy regulator Beclin-1. Consequently, it is plausible that activation of the 
IRE1/TRAF2/JNK branch of ER stress may regulate autophagy through modulation of 
Beclin-1 function and expression. One the other hand, Claudio Hetz and collaborators 
shown that XBP-1 ablation increases autophagy and protects from the toxicity induced by 
the aggregates of the enzyme superoxide dismutase 1 in a model of Amyotrophic Lateral 
Sclerosis. These data suggest that the XBP-1 may play a different role than TRAF2/JNK 
on the regulation of autophagy by the IRE1 branch of the UPR (107). A different 
mechanism may involve Death-associated protein kinase 1 (DAPK1) activation by ER 
stress leading to Beclin 1 phosphorylation, which induces autophagy by reducing Beclin 1 
binding to B-cell lymphoma-extra large (BCL-xL) (108, 109).  From another standpoint 
Kouroku et al. verified that ER stress caused activation of autophagy via PERK1 and eIF2 
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(101). Indication for a link between UPR-PERK branch and autophagy was obtained from 
ectopic expression of polyglutamine (polyQ) proteins. A dominant-negative form of PERK 
or genetic substitution of Serine 51 of eIF2α by Ala prevented polyQ protein-induced 
autophagy, strongly suggesting that PERK-dependent eIF2α phosphorylation plays an 
important role in the activation of autophagy in response to the accumulation of unfolded 
proteins (101). Calcium release due to ER stress has also been implicated in the pathway 
leading to autophagy induction (102).  
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7. ER stress in human diseases  
 
 In recent years, numerous works have revealed a close relation between the ER 
stress activated pathways and the genesis and progression of several inflammatory 
processes (80). The sensors of the UPR PERK, IRE1, and ATF6 contribute to up-
regulating inflammatory processes in several pathologies, including obesity, type 2 
diabetes, cancer, intestinal bowel and airway diseases and neurodegenerative diseases (61, 
84). ER stress does not assume always a deleterious effect and in cancer represents a 
paradoxal case. In one hand, current studies have revealed that various types of tumors 
might need an inflammatory microenvironment mostly because inflammation can be 
protumorigenic (110–112). On the other hand it was recently shown that ER stress 
accompanied by ROS production can promote the ‘regeneration’ of antitumor immunity by 
inducing immunogenic apoptosis in cancer cells (113). Recently, Abhishek and co-workers  
proposed that ER stress can help or delay disease evolution through the inflammatory 
pathways, depending on the cell type, disease stage, and type of ER stressor (Figure 11) 
(84).  
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Figure 11. Paradoxal effects of ER stress in health and disease. The crosstalk between inflammation and ER 
stress in the pathogenesis of several diseases. ER stress-induced inflammation has deleterious effects on 
pancreatic β cells, contributing to the progression of type 2 diabetes. As well, ER stress causes dysfunctions in 
adipocytes promoting the progression of obesity-associated inflammation that in turn is associated with 
suppression of insulin receptor signaling observed in type 2 diabetes. Similarly, ER stress-induced inflammation 
can change intestinal epithelial cells, Paneth cells, and goblet cells, probably assisting the progression of 
inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis. The progression of cystic 
fibrosis and cigarette smoke-induced chronic obstructive pulmonary disease has been also associated with ER 
stress-induced inflammation. The connection between ER stress-induced inflammation and cancer has 
dichotomous effects. Even though ER stress-induced inflammation has been publicized to support tumorigenesis, 
it has also been shown that ER stress prevents tumorigenesis by inducing immunogenic cell death-based 
antitumor immunity. Figure adapted from (84) 
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8. Effects of ER stress in dendritic cell immunobiology 
 
As stated in the initial topics of the present thesis, dendritic cells are heterogeneous cell 
populations with unique immunomodulatory abilities. Upon activation by a danger signal, 
DC become mature, enter draining lymphatic vessels and migrate to the T-cell zones in the 
draining lymph nodes where they present processed antigens to T lymphocytes. The 
maturation process is an extremely complex and well-coordinated succession of events 
characterized by changes in morphology, loss of endocytic/ phagocytic receptors, shift of 
chemokine receptors, resulting in acquisition of migratory capacity, up-regulation of co-
stimulatory molecules, alteration of secreted cytokines/chemokines and shift in lysosomal 
compartments (16). Although molecular events associated to this process have not yet been 
completely defined, it is known that activating mitogen-activated protein kinases, and 
activation of transcription factors such as nuclear factor κ-B (NF-κB), activating 
transcription factor-2 (ATF-2) or cAMP response element-binding protein (CREB) are 
intimately involved (2). However, despite some evidences, data regarding the role of ER 
stress and UPR signalling effectors on the immunobiology of DCs is very scarce.   
In a recent study, Goodall and co-workers investigated the effect of ER stress on the 
inflammatory cytokine production by monocyte-derived DC (114). They demonstrated that 
activation of ER stress, in combination with Toll-like receptor (TLR) agonists, markedly 
enhanced mRNA expression of the unique p19 subunit of IL-23, and also significantly 
augmented secretion of IL-23 protein. These effects were not seen for IL-12 secretion. The 
IL-23 gene was found to be a target of the ER stress- induced transcription factor C/EBP 
homologous protein (CHOP), which exhibited enhanced binding in the context of both ER 
stress and TLR stimulation. Knockdown of CHOP in U937 cells significantly reduced the 
synergistic effects of TLR and ER stress on IL-23p19 expression, but did not affect 
expression of other LPS-responsive genes (114). 
In another work, the endogenous changes and mechanisms underlying the maturation 
and activation of DC triggered by high mobility group box-1 protein (HMGB1)  were 
explored  (115). Since ER stress activates an adaptive UPR that facilitates cellular survival 
and repair, Xiao-mei Zhu and collaborators hypothesized that HMGB1 may regulate the 
function of DC by modulating ER stress (115). In this study, HMGB1 stimulation induced, 
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in a time- and dose-dependent manner, a significant ER stress response in DCs. This was 
demonstrated by the up-regulation of a number of ER stress markers such as GRP78. XBP-
1 gene silencing in splenic DCs, when compared with untransfected or nontargeting-
transfected DCs, induces decreased levels of co-stimulatory molecules CD80, CD86 as 
well as major histocompatibility complex (MHC)-II and cytokines after HMGB1 
treatment. Moreover, XBP-1 silenced DCs after treatment with HMGB1 failed to stimulate 
notable proliferation and differentiation of T cells, unlike normal DCs or nontargeting-
transfected DCs. Gene silencing of XBP-1 also resulted in down-regulation of the receptor 
for advanced glycation end products (RAGE) in splenic DCs treated with HMGB1. These 
findings demonstrate an important role for ER stress and its regulator XBP-1 in HMGB1-
induced maturation and activation of DCs (115). 
In another study where murine DCs were stimulated by polyIC, a synthetic mimic of 
virus dsRNA, the obtained data suggested that induced ER stress greatly potentiates the 
expression of inflammatory cytokines and IFN-β (95). Both toll-like receptor 3 and 
melanoma differentiation-associated gene-5 were involved in the enhanced IFN-β 
production, which was associated with increased activation of NF-kB and IRF3 signaling, 
as well as the observed XBP-1splicing. Surprisingly, silencing of XBP-1 reduced polyIC-
stimulated IFN-β expression in the presence or absence of ER stress, indicating that XBP-1 
may be essential for polyIC signaling and ER stress-amplified IFN-β production. 
Overexpression of spliced XBP-1 (XBP-1s) synergistically augmented polyIC-induced 
inflammatory response. This data suggest that evolutionarily conserved ER stress response 
and XBP-1 may function collaboratively with innate immunity to maintain DC cellular 
homeostasis (95). 
 
Therefore, much remains unknown regarding the impact of ER stress on DC response 
to danger signals such as ROS, pathogens, pathogen molecules, inflammatory cytokines, 
and allergens. 
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II. Hypothesis and Objectives 
 
 DCs maturation process triggered by skin sensitizers is at least in part due to the 
formation of ROS and alteration of cell redox status. In this process, ROS and depletion of 
thiol groups activate intracellular signalling pathways such as p38 MAPK and JNK. It is 
also known that ER and oxidative stress are interrelated. Oxidative stress can affect ER 
homeostasis and perturbations in protein folding can cause alterations in cellular redox 
status increasing the generation of ROS.  
 
Therefore, the work hypothesis for this dissertation is that: ER stress may be involved 
in skin sensitizers-induced DC maturation through a ROS dependent mechanism. 
 
 
 
 
 
 
Skin sensitizers (DNFB) 
ROS production 
MAPK activation 
ER stress 
DC maturation/ toxicity 
44 
 
The general objectives of the present work are: 
1. To study the ability of skin sensitizers to induce ER stress in dendritic cells; 
2. To elucidate possible mechanisms for the plausible ER stress induction; 
3. To evaluate the relevance of induced ER stress in apoptotic/ autophagic processes 
in sensitizer-treated cells; 
4. To evaluate the relevance of induced ER stress in the maturation/activation status 
of sensitizer-treated cells; 
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III. MATERIALS 
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III. Materials  
 
Resazurin, penicillin streptomycin, Roswell Park Memorial Institute (RPMI) 1640 medium 
were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Fetal Bovine Serum and 
TRIzol reagent were from Invitrogen (Paisley, UK). The protease and phosphatase 
inhibitor cocktails were obtained from Roche (Mannheim, Germany). Pharmacological 
inhibitors SB203580, U0126, SP600125 and Salubrinal were from Calbiochem (San 
Diego, California, USA) and 4-PBA form Merck (Darmstadt, Germany). The anti-tubulin 
antibody was purchased from Sigma Chemical Co. (St. Louis, Mo, USA). Antibodies 
against phospho-p44/p42 MAPK (ERK1/ERK2), phospho-p38 MAPK, phospho-
SAPK/JNK, phospho-eIF2α, CHOP, and total p38 MAPK were from Cell Signaling 
Technologies (Danvers, MA, USA). The anti-JNK1 and anti-ERK antibodies were from 
Millipore (Bedford, MA) and XBP1-s and GRP78 antibodies were purchased from 
Biolegend (San Diego, CA, USA). The alkaline phosphatase-linked secondary antibodies 
and the enhanced chemifluorescence (ECF) reagent were obtained from GE Healthcare 
(Chalfont St. Giles, UK), and the polyvinylidene difluoride (PVDF) membranes were from 
Millipore Corporation (Bedford, MA, USA). iScript kit and SYBR green were obtained 
from BioRad (Hercules, CA, USA). Primers were from MWG Biotech (Ebersberg, 
Germany). All other reagents were from Sigma Chemical Co. (St. Louis, Mo, USA) or 
from Merck (Darmstadt, Germany). 
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IV.Methods 
1. Cell culture 
 
 THP-1 human monocytic cell line (ATCC TIB-202, American Tissue Culture 
Collection, Manassas, VA) was cultured and maintained at a cell density between 0,2x10
6
 
and 1x10
6
 cells/mL in Roswell Park Memorial Institute (RPMI) 1640 medium 
supplemented with 10% of inactivated FBS, 25 mM glucose, 10 mM HEPES, 1 mM 
sodium pyruvate, 100 U/mL penicillin, 100 μg/mL streptomycin and 0.05 mM of 2-
mercaptoethanol. Cells were subcultured every 3–4 days and kept in culture for a 
maximum of 2 months. 
 
2. Resazurin Cell viability assay  
 
Cell viability was assessed by resazurin assay (116). Briefly, 0.2x10
6
 cells/well in a 96 
well plate were exposed to different DNFB concentrations (2 µM, 4 µM, 8 µM, 10 µM and 
15 µM), for 24 h. Three hours before the end of exposure, resazurin solution was added to 
each well to a final concentration of 50 µM. Absorbance was then read at 570 and 600 nm 
in a standard spectrophotometer MultiSkan Go (Thermo Fisher Scientific, Waltham, MA, 
USA). DNFB concentration that causes a loss of 20% viability (EC20 values) was 
determined by linear regression and used hereinafter in all experiment unless stated 
otherwise.  
 
3. Cell lysate preparation and Western blot analysis  
 
 To obtain the lysates for Western blot analysis, THP-1 cells were plated at 2.4x10
6 
cells/well in 6-well microplates in a final volume of 3 ml. The cells were then incubated 
with 8 µM DNFB for the indicated time periods (1 h, 2 h, 4 h, 8 h and 24 h) . As a positive 
control, parallel assays were performed with 10 µg/ml Tunicamycin, a known inducer of 
ER stress. In some experiments cells were exposed to different concentrations of DNFB (4 
µM, 8 µM, 16 µM and 24 µM) for 1 or 8 hours. To assess the possible crosstalk between 
the UPR response and the DNFB activation of MAPK kinases, cells were pre-treated for 
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1h with the pharmacological inhibitors 4-PBA (2.5 mM), NAC (5 mM), SB203580 (15 
µM), U0126 (15 µM), SP600125 (25 µM) and Salubrinal (25 µM) and then stimulated 
with 8 µM DNFB  for the indicated periods. At the end of exposure, cells were  washed in 
1 ml ice-cold PBS and harvested in RIPA lysis buffer (50 mM Tris–HCl (pH 8.0), 1% 
Nonidet P-40, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 2 mM EDTA and 1 
mM DTT) freshly supplemented with protease and phosphatase inhibitor cocktails (Roche, 
Mannheim, Germany). The nuclei and the insoluble cell debris were removed by 
centrifugation at 4ºC, at 12,000g for 10 min. The post-nuclear extracts were collected and 
used as total cell lysates. Protein concentration was determined using the bicinchoninic 
acid method and the cell lysates were denatured at 95ºC, for 5 min, in sample buffer (0.125 
mM Tris pH 6.8; 2%, w/v SDS; 100 mM DTT; 10% glycerol and bromophenol blue) for 
posterior use. Western blot analysis was performed to evaluate the effect of DNFB on 
several ER stress related proteins and on the activation of MAPK kinases and autophagy 
processes. Briefly, 30 µg of protein were separated by electrophoresis on a 12% (v/v) SDS-
polyacrylamide gel, transferred to polyvinylidene fluoride (PVDF) membranes and 
blocked with 5% (w/v) fat-free dry milk in Tris-buffered saline, containing 0.1% (v/v) 
Tween-20 (TBS-T), for 1 h at room temperature. Blots were then incubated overnight at 
4ºC with the primary antibodies. Antibodies and respective dilutions are indicated in Table 
3. The membranes were then washed with TBS-T and incubated, for 1 h at room 
temperature, with alkaline phosphatase-conjugated anti-rabbit (1:20,000) or anti-mouse 
(1:20,000) antibodies. The immune complexes were detected using the Enhanced 
Chemifluorescence reagent and the membranes were scanned for blue excited fluorescence 
on the Thyphon (GE Heatlcare, Chalfont St. Giles, UK) and analyzed using the software 
Total Lab 2009 (TotalLab Ltd, Durham, USA). To demonstrate equivalent protein loading, 
membranes were stripped and reprobed with antibodies to total ERK1/2, SAPK/JNK, p38 
MAPK, or with an anti-tubulin antibody. All the antibodies were prepared in 1% (w/v) fat-
free dry milk in TBS-T. Blots were developed with alkaline phosphatase-conjugated 
secondary antibodies and visualized by enhanced chemifluorescence.  
 
 
 
 
  
53 
 
Table 3. Dilutions of antibodies used for Western Blot. 
Antibody Dilution in TBS-T 1% milk 
phospho-eIF2α (Cell Signaling) 1/1000 
XBP1-s (BioLegend) 1/250 
GRP78 (Biolegend) 1/1000 
CHOP (Cell Signaling) 1/1000 
ATF4 (Cell Signaling) 1/1000 
phospho-ERK (Cell Signaling) 1/1000 
phospho- p38 (Cell Signaling) 1/1000 
phospho-JNK (Cell Signaling) 1/1000 
LC 3 B I/II (Cell Signaling) 1/1000 
p68 (Cell Signaling) 1/1000 
Tubulin (Sigma Aldich) 1/5000 
ERK (Millipore) 1/2000 
p38 (Cell Signaling) 1/1000 
JNK1 (Millipore) 1/1000 
 
4. RNA extraction 
 
 For RNA extraction, THP-1 cells were plated at 2.4x10
6 
cells/well in 6-well 
microplates in a final volume of 3 ml and treated with 8 µM DNFB or 10 µg/mL 
Tunicamycin during 3, 6 or 24h. When pharmacological inhibitors of MAPK kinases or 
ER stress inducers were used, drugs were added 1 hour before DNFB stimulation. Total 
RNA was isolated from
 
cells with the TRIzol
®
 reagent according to the manufacturer's 
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instructions. Briefly, cells were washed with ice-cold PBS harvested and homogenized in 1 
ml of Trizol by pipetting vigorously. After addition of 200 μL of chloroform the samples 
were vortexed, incubated for 2 min at room temperature and centrifuged at 12,000×g, for 
15 min, at 4ºC. The aqueous phase containing RNA was transferred to a new tube and 
RNA precipitated with 500 µL of isopropanol for at least 10 minutes at room temperature. 
Following a 10 minutes centrifugation at 12,000g, the pellet was washed with 1 ml 75% 
ethanol and resuspended in 30 μl 60ºC heated RNase free water. The RNA concentration 
was determined by OD260 measurement using a Nanodrop spectrophotometer 
(Wilmington, DE, USA). Quality was inspected for absence or genomic DNA, protein or 
guanidine isotiocianate contamination trough assessment of 260/280 and 260/230 ratios. 
RNA was stored in RNA Storage Solution (Ambion, Foster City, CA, USA) at -80ºC until 
use. 
 
5. Real-time Reverse Transcription Polymerase Chain Reaction  
 
 For the synthesis of cDNA the iScript
TM
 Select cDNA Synthesis Kit was used 
according to manufacturer instructions. Briefly, 2 µL of random primers and the necessary 
volume of RNase-free water to complete 15µL were added to 1 µg of total RNA. After 
this, 5µL of a Master Mix containing 1 µL of iScript reverse transcriptase and 4 µL of 5x 
Reaction Buffer were added to each sample. A protocol for cDNA synthesis was run on all 
samples (5 min at 25ºC, 30 min at 42ºC, 5 min at 85ºC and then put on hold at 4ºC). After 
the cDNA synthesis, the samples were diluted with RNase-free water up to a volume of 
100 µL. Real-time PCR was performed in a 20 µL volume containing 2,5 µL cDNA (25 
ng), 10 µL 2x Syber Green Supermix, 2 µL of each primer (250 nM) and 3,5 µL H2O PCR 
grade. Samples were denatured at 95ºC during 3 min. Subsequently, 40 cycles were run for 
10 sec at 95ºC for denaturation, 30 sec at the appropriate annealing temperature and 30 sec 
at 72ºC for elongation. Real-time RT-PCR reactions were run in duplicate for each sample 
on a Bio-Rad My Cycler iQ5. Primers were designed using Beacon Designer
®
 Software 
v8.0, from Premier Biosoft International and thoroughly tested. Primer sequences used are 
given in Table 4. 
 On each real-time PCR plate there was a non-template control present for each pair 
of primers analyzed. For determination of primer-pair specific efficiencies, a 4 points 
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dilution series of control sample for each pair of primers was run on each experiment 
(117). Amplification reactions were monitored using SYBR-Green reagent. After 
amplification, a threshold was set for each gene and Ct-values were calculated for all 
samples. Gene expression changes were analyzed using the built-in iQ5 Optical system 
software v2.1. The software enables analyzing the results with the Pfaffl method (118), a 
variation of ΔΔCT method corrected for gene-specific efficiencies, and to report gene 
expression changes as relative fold changes compared to control samples. The results were 
normalized using HPRT-1 and GAPDH as reference genes. These genes were determined 
with Genex
®
 software (MultiD Analyses AB) as the most stables for the treatment 
conditions used.  
 
 
Table 4. Primer sequences used for qRT-PCR assays 
Gene Name Forward primer Reverse primer RefSeq ID 
GAPDH ACAGTCAGCCGCATCTTC GCCCAATACGACCAAATCC NM_002046.4 
HPRT1 TGACACTGGCAAAACAATG GGCTTATATCCAACACTTCG NM_000194.2  
IL1β GCTTGGTGATGTCTGGTC GCTGTAGAGTGGGCTTATC NM_000576.2  
IL8 CTTTCAGAGACAGCAGAG CTAAGTTCTTTAGCACTCC NM_000584.3  
CD86 GAACCTAAGAAGATGAGT TCCAGAATACAGAAGATG NM_175862.4  
CD40 TGATAGTGAACAACTGGAA CCATAGGCAATATACATACATAA NM_001250.4  
DDIT3 TAAAGATGAGCGGGTGGCAG CTGCCATCTCTGCAGTTGGA NM_004083.5  
HSPA5 TCTTGTTGGTGGCTCGACTC ATCTGGGTTTATGCCACGGG NM_005347.4  
VIMP AACCCGTTGTCTGGTGAAGG GAAAAGCGTGCGTAAGGCAA NM_203472.1  
HERPUD1 GTCTCAGGGACTTGCTTCCA CCTTGGCGTTGATTTCTGGC NM_014685.3  
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6. ROS Detection by Immunocytochemistry  
 
 To measure reactive oxygen species (ROS) formation after DNFB exposure, the 
fluorogenic probe Cell ROX® Green Reagent was used. This probe, upon oxidation, binds 
to DNA with a strong increase in fluorescence. Therefore its signal is primarily localized in 
the nucleus and mitochondria. The fluorescence resulting from CellROX® Oxidative 
Stress Reagent was captured by conventional fluorescence microscopy. For this procedure 
THP-1 cells (1x10
5
) were plated in Poly-L-Lysine coated wells of µ-Chamber slides 
(IBIDI GmbH, Germany). After an overnight stabilizing period the cells were loaded with 
5 μM Cell ROX® Green Reagent for 30 min and then washed three times with culture 
medium. Following this, cells were treated with 8 µM DNFB during 30 min and then 
washed with PBS before fixation during 15 min with 4% paraformaldehyde. The cells were 
then permeabilized with 0.2% (v/v) Triton-X-100, 200 mM Glycine in PBS for 10 min at 
room temperature and F-actin was stained by adding Alexa Fluor 555 Phalloidin 
(Molecular Probes) 1:100 in PBS during 30 min. After three washing steps cells were 
finally exposed to nuclear label DAPI (100 nM) for 2 min and the slides analyzed with a 
fluorescent microscope (Nikon Corporation, Japan) at 630X magnification. Images were 
captured with a DS-Fi2 High-definition digital camera and analyzed in NIS-Elements 
Imaging Software (Nikon Corporation, Japan). 
 
7. Cell Cycle analysis by flow cytometry 
 
 The effect of DNFB exposure on THP-1 cell cycle was analyzed by flow cytometry 
with Propidium Iodide (PI). PI binds to DNA by intercalating into the double stranded 
macromolecule being the quantity of blinded dye proportional to the quantity of DNA. The 
quantification of the content DNA allowed us to know the distribution of a cell population 
along the different phases of the cell cycle. For this procedure 1x10
6
 cells were plated in 12 
multiwell plates in a final volume medium of 1.2 mL and pre-treated with 2.5 mM PBA, 
25 µM SP600125 or 25 µM Salubrinal and then stimulated with 8 µM DNFB  during 24 
hours. After the incubation time, cells were centrifuged for 5 min at 300 g, washed with 
PBS and the pellet resuspended in the residual liquid. The cells were then fixed by adding 
drop wise 200 μL of ice cold 70% ethanol while slowly vortexing. The cells were left in 
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ethanol at – 4ºC until analysis. For PI staining, the cells were washed in 1 ml of 2% BSA in 
PBS and centrifuged during 5 min at 500g. The supernatant was removed and the pellet 
was resuspended in the residual liquid. Next, 0.5 mL of propidium iodide solution 
(PI/RNase) was added to the pellet and mixed well. The samples were incubated for 15 
minutes at room temperature before to analysis.  
 
8. Statistical analysis  
 
 The results are presented as mean ± S.D., and the statistic difference between two 
groups was determined by the two-sided unpaired Student’s t test. For multiple group 
comparisons, the One-Way ANOVA test, with a Bonferroni´s Multiple Comparison post-
test was used. The tests were performed using GraphPad Prism, version 5.02 (GraphPad 
Software, San Diego, CA, USA).  Statistically significant values are as follows: *p <0.05, 
**p <0.01, ***p <0.001, ****p <0.0001 
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V. Results  
 
1. Determination of EC20 DNFB concentration 
 
 Resazurin was used to assess the metabolic capacity of cells and by extension their 
viability. This method provides a rapid and easy way to estimate the number of viable cells 
as they reduce resazurin into resorufin leading to an increase in emitted fluorescence and a 
change in medium color. Since a certain level of cytotoxicity is required for effective DC 
activation (119) we determined the concentration of DNFB that induced a maximum of 
20% cytotoxicity (EC20), and used this concentrations along the subsequent experiments 
(Figure 12).  
  
Figure 12. Effect of DNFB on THP-1 cell viability. 0.2x10
6
 cells/well in a 96 well plate were exposed 
during 24 hours at the indicated concentrations (2 µM, 4 µM, 8 µM, 10 µM and 15 µM). The concentration 
that causes a 20% loss in cell viability (EC20)  was  determined by linear regression. 
 
 According to the established criterion, the determined EC20 DNFB concentration 
was 8 µM. This concentration was used hereinafter in all experiment unless stated 
otherwise. From our results we also observe that for concentrations superior to 4 µM, cell 
viability decreases linearly with the increase of DNFB. 
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2.  DNFB treatment induces a rapid increase in ROS production 
 
 The production of ROS following exposure of DCs to skin sensitizers is well 
documented and viewed as a primary danger signal that subsequently triggers intracellular 
signaling cascades that ultimately culminates in cell maturation (120). As we hypothesize 
that DNFB may trigger ER stress through a ROS dependent mechanism we initially 
analyze its ability to effectively induce oxidative stress in THP-1 cells.  
 
 For this propose we measured, by immunofluroscence microscopy, the levels of 
oxidative stress with the ROS sensitive probe Cell ROX® Green Reagent (Figure 13). This 
probe is weakly fluorescent while in a reduced state but is converted in a highly fluorescent 
form upon oxidation by peroxides, peroxynitrite, or hydroxyl radical and subsequent 
binding to DNA. The signal is therefore primarily localized in the nucleus and 
mitochondria. We observed that DNFB causes a strong and rapid ROS generation in THP-
Figure 13. DNFB treatment induces a rapid increase in ROS levels. THP1 cells were loaded with the fluorogenic 
probe Cell ROX® Green Reagent (green) for 30 min and then treated with 8 µM DNFB during additional 30 min. 
Alexa Flúor 555 Phalloidin was used for visualization of F actin cytoskeleton fibers (red) and DAPI to highlight the 
nuclei (blue). Images representative of different fields were acquired with a DS-Fi2 High-definition digital camera 
coupled to a Nikon fluorescent microscope (magnification 630x) and analyzed in NIS-Elements Imaging Software 
(Nikon Corporation, Japan). 
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1 exposed cells, confirming that this event may represent an early danger signal during the 
sensitization phase of allergic contact dermatitis.  
 
3.  DNFB induces a rapid and sustained phosphorylation of eIF2α, an up 
regulation of ATF4 and a posttranslational modification of the ER major 
chaperone GRP78 
 
 To test our hypothesis that skin sensitizers such as DNFB may induce ER stress in 
DC, affecting their immunobiology, we started to test its effects on the levels of key 
proteins from the three branches of the UPR. THP-1 cells were incubated with 8 µM 
DNFB for the indicated time periods (1h, 2h, 4h, 8h and 24h) and the protein levels of 
GRP78, CHOP, p-eIF2α, ATF4 and XBP-1s (Figure 14) were assessed by Western Blot. 
Parallel experiments were performed with 10 µg/ml Tunicamycin a known inducer of ER 
stress.  
 
Figure 14. Effects of DNFB (A) and Tunicamycin (B) on the levels of several ER stress related proteins. 
Proteins were extracted after 1h, 2h, 4h, 8h and 24h of stimulation and 30 µg of protein were loaded on a 
12% SDS-polyacrylamide gel. Protein levels of GRP78, CHOP, p-eIF2α, ATF4 and XBP-1s were assessed 
by Western Blot. The results are representative of at least three independent experiments. To ensure that 
equal protein loading between samples, the membranes were stripped, and reprobed with a β-Tubulin 
antibody. C, control 
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 We observed that, in contrast to Tunicamycin, DNFB does not trigger a canonical 
ER stress response. As expected, Tunicamycin induced the expression of proteins from the 
three UPR branches, namely CHOP, GRP78, ATF4, phosphorylated eIF2α and the protein 
resultant from the spliced form of XBP1 mRNA (Figure 14B). From the studied ER stress 
markers, DNFB appears to mainly affect the PERK-eIF2α-ATF4 branch, causing a strong 
and time sustained phosphorylation of eIF2α and an early increase of ATF4 levels (Figure 
14A). Of note is also the fact that DNFB treatment although just slightly up regulates the 
levels of chaperone GRP78, causes the appearance of a low molecular weight 
immunoreactive protein form in a time dependent way (Figure 14A). This suggests that 
DNFB may induce a posttranslational modification in GRP78 protein with possible 
consequences to its functions. 
 
4. DNFB treatment modestly affects the transcription of ER stress related genes  
 
 Additionally, we performed quantitative real-time RT-PCR experiments to evaluate 
the effect of DNFB on the expression of several genes under control of the unfolded 
protein response. THP-1 cells were treated with 8 µM DNFB and 10 µg/mL Tunicamycin 
during 3, 6 or 24 h and the mRNA levels of CHOP, GRP78, SEPS1 and HERP were 
analyzed (Figure 15). 
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 Obtained results revealed that THP-1 exposure to DNFB modestly induce common 
ER stress controlled transcripts. Among studied genes, the most robustly up regulated were 
the detoxifying proteins SEPS1 and HERP, with maximal increases observed at 3h post 
treatment (3.9 and 6.7 fold change relatively to control for SEPS1 and HERP, 
respectively). Regarding CHOP and GRP78, despite statistically significant increases 
observed at 3h post treatment, they are very modest and the levels rapidly decrease to 
values similar to untreated cells (Figure 15A). In contrast, treatment of THP-1 cells with 
Tunicamycin caused a significant and sustained increase of all the genes analyzed, being 
CHOP and HERP the most robustly up regulated (Figure 15B). 
 
 
 
 
Figure 15. Effect of DNFB (A) and Tunicamycin (B) in the mRNA levels of ER stress related 
genes. RNA was extracted after the 3h, 6h and 24h of stimulation. The relative expression of 
indicated genes was assessed by Quantitative Real Time-PCR and normalized using HPRT-1 
and GAPDH as reference genes. Each value represents the mean ± S.D. from at least three 
independent experiments. . (*p<0.05; **p<0.01; ***p<0,001 DNFB or Tunicamycin vs control;  
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5. Effect of DNFB over p-eIF2α, GRP78 and ATF4 is concentration dependent 
and related to induced redox-imbalance 
 
 In order to evaluate the relationship between DNFB-induced redox imbalance and 
the observed effects on p-eIF2α, GRP78 and ATF4, cells were pre-treated with the 
antioxidant N-acetylcysteine (NAC) and the levels of these proteins subsequently analyzed 
by Western Blot (Figure 16). 
 
Figure 16. Effect of different concentrations of DNFB and NAC  on p-eIF2α, GRP78 and ATF4 protein 
levels. Cells were exposed to 4µM, 8µM, 16µM and 24µM of DNFB. It was used 16µM of DNFB 
simultaneously with NAC. Proteins were extracted after 8 hours to analyse the production of GRP78, ATF 4 
and 1hour to analyse the production of p-eIF2α. After extraction, 30µg of the protein lysates was loaded on 
the gel. Protein expression of p-eIF2α, GRP78 and ATF4 was assessed with Western Blot. Equal protein 
loading between samples was controlled with β-Tubulin. Data are representative of three independent 
experiments. C, Control.  
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We observed that the effects of DNFB over the analyzed proteins were dose-
dependent. A substantial increase of p-eIF2α, ATF4 and posttranslational modified form of 
GRP78 was observed when cells were exposed to growing concentrations of DNFB 
(Figure 16 A and B). However, in cells exposed to DNFB during 8h and to higher 
concentrations (24 µM) the effects were significantly lower. This suggests that cells are 
only able to trigger recovery mechanisms until the insult reaches a given threshold and for 
stress levels beyond this limit predominate signals conducting to cell death. Pre-treatment 
with N-acetyl-L-cysteine (NAC) markedly suppressed the DNFB-induced phosphorylation 
of eIF2α and the expression of ATF4. This indicates that the observed activation of 
eIF2α/ATF4 UPR branch is, at least in part, a consequence of redox imbalance caused by 
DNFB.    
 
6. Crosstalk between the DNFB-activated MAPK kinases and the UPR response  
 
 The activation of mitogen-activated protein kinases (MAPK), particularly p38 
MAPK, is in DC a common observation after skin sensitizers exposure (49, 119). 
Therefore, we assessed in a first step the effects of DNFB on the levels of phosphorylated 
p-38, ERK1/2 and JNK1/2 in a 24 hours’ time-course experiment. As can be seen in Figure 
17A, exposure to DNFB rapidly and intensively activates p38 MAPK and JNK signaling 
pathways in THP-1 cells. These two kinases presented however a distinct behaviour over 
time: while JNK1/2 remained highly phosphorylated during the 24h of the assay, p38 
presented maximal activation at 1h post cell treatment with phosphorylation progressively 
decaying over time (Figure 17A). From the obtained results, ERK1/2 is in THP-1 cells 
constitutively activated, with high phosphorylation levels detected in untreated cells. 
Moreover, DNFB treatment does not induced substantial ERK1/2 activation over the 
detected basal levels.  
 Next we analyzed the existence of a possible crosstalk between the DNFB-activated 
MAPKs and the observed eIF2α phosphorylation. For this propose cells were pre-treated 
with the pharmacological inhibitors NAC (5 mM), SB203580 (15 µM), U0126 (15 µM), 
SP600125 (25 µM) and Salubrinal (25 µM) for 1h and exposed to 8 µM DNFB during an 
additional hour (Figure 17B). 
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Figure 17. (A) Effect of DNFB treatment on the activation of MAPK kinases. Proteins were extracted 
after 1h, 2h, 4h, 8h and 24h of stimulation and 30 µg of protein were loaded on a 12% SDS-polyacrylamide 
gel. Phosphorylated levels of JNK1/2, p38 and ERK1/2 were assessed by Western Blot. To ensure equal 
protein loading between samples, the membranes were stripped and reprobed with total JNK1, total p38, total 
ERK1/2 antibodies. The results are representative of three independent experiments. (B) Evaluation of the 
possible crosstalk between DNFB-induced MAPK activation and eIF2α phosphorylation. THP1 cells 
were pre-treated for 1h with the NAC (5 mM), SB203580 (15 µM), U0126 (15 µM), SP600125 (25 µM) or 
Salubrinal (25 µM), and then stimulated with 8 µM DNFB. Proteins were extracted after 1h of stimulation 
and 30 µg of protein were loaded on a 12% SDS-polyacrylamide gel. Phosphorylated levels of JNK1/2, p38 
and eIF2α were assessed by Western Blot. The results are representative of two independent experiments. 
Equal protein loading between samples was controlled by stripping and reprobing membranes with total 
JNK1, total p38 and β-Tubulin antibodies. C, control; NAC, N-acetylcysteine; SAL, Salubrinal. 
 
We observed that pre-treatment of cells with N-acetylcysteine (NAC) efficiently 
reduces the DNFB-induced phosphorylation of JNK, p38 and eIF2α. These results suggest 
that in fact ROS production and resultant redox imbalance is a key early danger signal that 
is central to the activation of several signalling pathways in skin sensitizers-exposed DC. 
Regarding the possible crosstalk between DNFB-induced MAPKs activation and eIF2α 
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phosphorylation we observed that the inhibition of p38 kinase activity by SB203580 and 
the inhibition of phosphorylation of JNK1/2 by SP600125 are accompanied by a slight 
decreased in the levels of p-eIF2α. This observation points to a possible link between the 
activity of these MAPK kinases and the regulation of eIF2α phosphorylation in THP-1 
cells triggered by the allergen DNFB. In contrast, eIF2α phosphorylation status seems to 
not have influence in the activation of MAPKs, as shown in Figure 17B. Treatment of cells 
with the eIF2α specific phosphatase inhibitor Salubrinal resulted in increased 
phosphorylation of eIF2α without relevant effects on the levels of p-JNK1/2 and p-38.  
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7. Evaluation of DNFB effects in Autophagy 
 
 Given that activation of PERK-eIF2α-ATF4 was shown to regulate important 
aspects of autophagic process (121) we assessed the possible induction of autophagy in 
DNFB-treated cells. For this propose we analyzed by Western blot the levels of 
microtubule-associated protein light chain 3 (LC3) and p62 in cells exposed to 8 µM 
DNFB for the indicated time periods (1h, 2h, 4h, 8h and 24h) (Figure 18A) or to different 
DNFB concentrations (4 µM, 8 µM, 16 µM and 24 µM) during 8 hours (Figure 18B). LC3 
and p62 were widely used to monitor autophagy:  the amount of LC3‑II is directly 
correlated with the number of autophagosomes (122) and p62 protein levels allow to 
distinguish between induction of autophagy or blockade of autophagic process (99).  
 
  
 DNFB treatment induced a time and concentration dependent increase in the levels 
of LC3BII. As the amount of LC3B at a certain time point does not specifically indicates 
activation of autophagy, and may evenly be caused by a blockade of autophagic flux, we 
checked the levels of p62.  p62 protein  (sequestosome 1) binds to LC3, serving as a 
Figure 18. Time course and effect of different DNFB concentrations on the expression of LC 3 I/II and 
p62. Cells were exposed to DNFB for the indicated time periods (A) or to the indicated concentrations (B). 
After extraction, 30 µg of protein were loaded on a 12% SDS-polyacrylamide gel and Western blot was 
performed to evaluate the levels of LC3 and p62. To ensure equal protein loading between samples, the 
membranes were stripped, and reprobed with a β-Tubulin antibody. The results are representative of two 
independent experiments. C, control. 
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Diploid: 100% 
Dip G1: 62.83% at 48.53 
Dip G2: 2.34% at 97.01 
Dip S: 34.83% G2/G1: 2.00 
Apoptosis: 45.91% 
A
. . 
Diploid: 100% 
Dip G1: 60.83% at 51.41 
Dip G2: 7.61% at 99.22 
Dip S: 31.56% G2/G1: 1.93 
Apoptosis: 0.28% 
B 
selective substrate of autophagy (122). Therefore, in situations where autophagy is 
activated, the levels of p62 are expected to decrease.  We verified along the time course 
experiment that DNFB-treated cells do not present decreased levels of 62. Rather, we 
observed a slight concentration-dependent increase in cells treated during 8 hours.  Taken 
together these results suggest that DNFB treatment does not activate autophagy in DC and 
but rather block the autophagic flux.  
 
 
 
8. Apoptosis and cell cycle analysis by Flow Cytometry 
 
 A major consequence of eIF2α phosphorylation is the blockade of mRNA 
translation leading to inhibition of global protein synthesis. Transient inhibition of 
translation has been suggested to contribute to the cell survival by repressing cyclin D1 and 
p53 expression, which lead to cell cycle arrest (123). As we detected a sustained eIF2α 
phosphorylation in DNFB-treated DC we tried to address if this event modulates the 
normal cell cycle. The effect of DNFB on THP-1 cell cycle was analyzed by flow 
cytometry with Propidium Iodide (PI). This procedure allows the distribution of a cell 
population along the different phases of the cell cycle according to its DNA content. 
Additionally it also enables the estimation of the apoptotic cells (Figure 19A).  
 
 
 
 
Cells stimulated with Staurosporine Control 8 h 
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Diploid: 100% 
Dip G1: 52.68% at 53.23 
Dip G2: 9.98% at 103.75 
Dip S: 37.34% G2/G1: 1.95 
Apoptosis: 0.01% 
C
L
L 
Diploid: 100% 
Dip G1: 57.36% at 53.10 
Dip G2: 9.80% at 103.14 
Dip S: 32.84% G2/G1: 1.94 
Apoptosis: 7.81% 
E 
Diploid: 100% 
Dip G1: 58.15% at 51.82 
Dip G2: 7.17% at 101.95 
Dip S: 34.67% G2/G1: 1.97 
Apoptosis: 11.82% 
F 
Diploid: 100% 
Dip G1: 50.57% at 51.19 
Dip G2: 10.06% at 100.28 
Dip S: 39.37% G2/G1: 1.96 
Apoptosis: 3.19% 
G 
Diploid: 100% 
Dip G1: 58.28% at 51.71 
Dip G2: 13.01% at 101.97 
Dip S: 28.71% G2/G1: 1.97 
Apoptosis: 3.23% 
H 
 
 
 
 
 
DNFB 4 µM-8 h                                                                        DNFB 8 µM-8 h 
 
 
 
 
 
 
DNFB 24 µM-8 h 
DNFB 16 µM-8 h 
Control  24 h DNFB 8 µM-24 h 
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I 
Diploid: 100% 
Dip G1: 67.03% at 52.59 
Dip G2: 9.56% at 103.70 
Dip S: 23.41% G2/G1: 1.97 
Apoptosis: 6.48% 
Diploid: 100% 
Dip G1: 58.62% at 52.02 
Dip G2: 18.69% at 101.67 
Dip S: 22.69% G2/G1: 1.95 
Apoptosis: 1.77% 
J 
DNFB 8 µM + 4-PBA 2,5Mm-24 h                                             DNFB 8 µM + Salubrinal 25µM-24 h 
Figure 19. Effect of DNFB exposure on THP-1 cell cycle. Flow cytometry was done after 8 and 24 hours 
of stimulation with DNFB. Cells were stained with PI for the different conditions. (A) Cells stimulated with 
Staurosporine, (B) control 8 h (C) DNFB 4 µM-8 h, (D) DNFB 8 µM-8 h, (E) DNFB 16 µM-8 h, (F) DNFB 
24 µM-8 h, (G) control 24 h (H) DNFB 8 µM-24 h (I) DNFB 8 µM + 4-PBA 2,5Mm-24 h and (J) DNFB 8 
µM + Salubrinal 25µM-24 h. Cells were distributed along the different phases of the cell cycle: cells in G2 
and M phases that have double DNA content of those in G0 and G1 phases, and a region correspondent to 
cells in phase S. The percentage of apoptotic cells on the different conditions is indicated in each histogram. 
As a positive control of apoptosis THP-1 cells were treated for 8 h with Staurosporine. The results are 
representative of one independent experiment. 
 
 Concerning the effects of DNFB on THP-1 cell cycle, we do not detect evidences 
of cell cycle arrest. Regarding the effects of DNFB on programmed cell death, obtained 
results revealed that apoptosis is barely detectable in cells treated with up to 8 µM DNFB 
for 8 hours (0.03%).  However, populations with apoptotic characteristics increased 
significantly after exposure to 16 µM (7.81%) and 24 µM DNFB (11.82%). In 24h 
exposure experiments we observed that 8 µM DNFB (EC20 concentration) barely 
increased the percentage of apoptotic cells: 3.19% for control vs 3.23% for DNFB treated 
cells. Prevention of DNFB-induced ER stress by 4-PBA resulted in a 2 fold increase in 
apoptosis (6.48%) while cell exposure to eIF2α dephosphorylating inhibitor salubrinal 
caused the opposite effect (1.77% apoptotic cells). These results suggest that DNFB- 
activation of eIF2α-ATF4 UPR branch may play an important role in cell recovery from 
redox imbalance.  
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9. Activation of p-eIF2α – ATF4 axis is required for DNFB induced IL8 and 
HMOX gene transcription 
 
 Finally, we addressed the relevance of eIF2α-ATF4 activation to DNFB-induced 
DCs maturation/inflammatory status. For this propose THP-1 cells were pre-treated with 5 
mM NAC, 2.5 mM 4-PBA or 25 µM Salubrinal  and stimulated with 8 µM DNFB for 
additional 24h. Then, quantitative real-time RT-PCR was performed to evaluate the mRNA 
levels of pro-inflammatory cytokines IL-1β and IL-8, co-stimulatory molecule CD86 and 
of the detoxifying protein HMOX. We observed that DNFB causes a significant increase in 
the mRNA levels of all the genes analyzed and that this induced transcription was almost 
completely blocked by cell pre-treatment with NAC (Figure 20 A,B,C and D) . Once again 
this result evidences the key role of ROS in skin sensitizers-induced DC 
activation/maturation.  DNFB-induced transcription of CD86 and IL-1β was shown to be 
significantly decreased by both Salubrinal and 4-PBA (Figure 20 A and C).  Interestingly, 
HMOX and IL-8 mRNA levels where significantly increased by pre-treatment with 
Salubrinal (Figure 20 B and D) indicating that these genes are under transcriptional control 
of  eIF2α-ATF4 axis. In fact, the marked increase in the expression of the detoxifying 
protein HMOX in cells where eIF2α is maintained in a phosphorylated state by Salubrinal 
may partially explain the observed decrease apoptosis in this condition.  This corroborates 
our hypothesis that eIF2α-ATF4 pathway activation is a key event in cell response to 
DNFB-induced oxidative insult.  
  
A B 
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Figure 20. Effect of DNFB, NAC, Salubrinal and 4-PBA in the mRNA levels of CD86 (A), HMOX (B), 
IL-1β (C) and IL-8 (D). THP-1 cells were pre-treated with NAC (5 mM), 4-PBA (2.5 mM) and Salubrinal 
(25 µM) for 1h and then stimulated with 8 µM DNFB during 24h. Quantitative Real Time RT-PCR was then 
performed to evaluate CD86, HMOX, IL-1β and IL-8 mRNA levels.  Each value represents the mean ± S.D. 
from two independent experiments (****p<0.0001 control vs DNFB and; 
##
p<0.01; 
###
p<0.001; 
####
p<0.0001 
DNFB vs DNFB+inhibitors).Gene expression changes were analyzed using the built-in iQ5 Optical system 
software v2.1. NAC, N-acetylcysteine; SAL, Salubrinal. 
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VI.Discussion  
 
 Allergic contact dermatitis, a delayed-type hypersensitivity reaction caused by skin 
exposure to low molecular weight reactive chemicals, is one of the most ordinary 
occupational diseases in developed countries.  A keystone in the pathogenesis of this 
disease is the chemical-induced activation/maturation of DCs. Mature DCs migrate to 
lymph nodes and effectively present processed antigens to naïve T cells, polarizing that 
way effector and memory T cell populations.  The DC maturation process was shown to be 
strongly dependent on initial danger signals such as  imbalance of cell redox status  and 
release of cellular ATP (45, 46, 120).  ROS deplete thiol groups and cause  the activation 
of  intracellular signaling pathways such as p38 MAPK and JNK that ultimately drive 
phenotypical, and functional  changes that characterize DC maturation (49, 50). In recent 
years numerous studies have shown a close link between ER stress, ROS production and 
the pathogenesis of several chronic inflammatory, neurodegenerative, cardiovascular and 
autoimmune diseases such as type 1 diabetes (47, 93, 124, 125). Oxidative stress affects 
ER functions through perturbation of protein processing/transport and by disturbing 
calcium ER homeostasis and perturbations in protein folding cause alterations in cellular 
redox status by increasing mitochondrial ROS production (45, 47, 54). Despite recent 
intense research activity regarding ER stress and its consequences, the information 
regarding its effects in DC immunobiology remains scarce. Therefore, in this work we 
assessed the effects of the extreme sensitizer DNFB on the induction of ER stress in THP-1 
cells, as well as the relevance of mounted UPR for cell maturation/toxicity.  
 As in our hypothesis sensitizers-induced redox imbalance may result in ER stress 
we started to evaluate the ability of DNFB to effectively induce oxidative stress in THP-1 
cells. In accordance to recent works we observed a rapid and strong increase of ROS in 
DNFB treated cells (120, 126, 127). Electrophilic chemicals such as DNFB react with 
cysteine residues of proteins and cause a rapid depletion of intracellular GSH levels 
leading to an accumulation of ROS. Next we directly assessed the ability of DNFB to 
trigger ER stress in THP-1 cells through evaluation of the levels of ER stress sensory 
proteins and transcription of related genes. We found that in contrast to Tunicamycin, a 
well establish ER stressor (62, 70, 92, 95), DNFB does not canonically activates the three 
UPR branches, whit minimal effects on XBP1 splicing, CHOP/GADD153 and GRP78 
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expression. Moreover, DNFB treatment modestly affected the transcription of these genes 
being the genes coding for the detoxifying proteins SEPS1 and HERP the most robustly up 
regulated. SEPS1 has been reported as a new ER stress-dependent survival factor that 
protects macrophage against ER stress-induced cellular dysfunction (96) and HERP, a 
mammalian homolog of Usa1p, was shown to be up-regulated in response to ER stress in a 
variety of cell lines being crucial for ERAD  (62, 73, 107, 125). Therefore, DNFB induced 
effects over ER stress related genes point to the activation of an UPR branch mainly 
involved in cell recovery from insult. 
 Although DNFB slightly affected the transcription and expression of intact GRP78, 
cell treatment caused a time and concentration-dependent appearance of a low molecular 
weight immunoreactive form of the protein, suggesting that a posttranslational 
modification may be occurring. Several studies report GRP78 post-translational 
modifications such as  phosphorylation, ADP ribosylation and oxidative cleavage, being 
the existence of these modified forms correlated with the physiological activity of the ER 
(128–130). Attending that the protein form detected in DNFB-treated cells presents a low 
molecular weight it is plausible to speculate that DNFB-induced ROS formation may be 
cause the oxidative cleavage of GRP78.  
Among other ER stress sensory proteins analyzed we observed that DNFB causes a 
rapid and sustained phosphorylation of eIF2α and an increase in the expression of the bZIP 
transcription regulator ATF4. These effects were shown to be concentration-dependent and 
markedly abrogated by cells pretreatment with the antioxidant NAC. It is therefore shown 
a direct relation between DNFB-induced redox imbalance and the activation of eIF2α – 
ATF4 axis, leading us to hypothesize that DNFB may be selectively activating the PERK- 
eIF2α – ATF4 branch of UPR. This result must however be interpreted with caution 
because in mammals eIF2α may also be phosphorylated by PKR, a sensor of viral RNA,  
by general control non depressible 2 (GCN2), a sensor of aminoacid starvation,  and by  
heme-regulated inhibitor (HRI), in heme depletion conditions (86).  
 Direct evaluation of PERK phosphorylation was shown to be difficult, and in fact 
we were not able to detect phosphorylated-PERK, neither in DNFB or Tunicamycin-
treated cells. However, our hypothesis that DNFB is activating eIF2α – ATF4 axis through 
ER stress effector kinase PERK is strengthen by the fact that besides the phosphorylation 
of eIF2α in serine 51, PERK was recently shown to directly phosphorylates and activates 
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NRF2 (78), a transcription factor intimately related to cell response to skin sensitizer-
induced electrophilic stress (131). 
   Like IRE1 and ATF6, PERK is believed to bind the chaperone protein GRP78 
under normal conditions. As unfolded proteins accumulate during ER stress, GRP78 
dissociates, allowing PERK to autophosphorylate and dimerize, which induces 
transphosphorylation and consequent eIF2α phosphorylation in serine-51 (123). The main 
consequence of eIF2α phosphorylation is a rapid mRNA translation attenuation in order to 
prevent the influx of newly synthesized polypeptides into the stressed ER (62). Besides this 
general inhibition of protein synthesis, specific proteins such as ATF4 are up-regulated. 
The transcription factor ATF4 controls the expression of ER stress target genes including 
amino acid transporters, detoxifying proteins and cell death related proteins, among others 
(47). CHOP is one of the most studied targets of ATF4, playing a crucial role in ER stress-
induced apoptosis. Although increased levels of ATF4 were detected in DNFB-treated 
cells, we do not observe a concomitant expression of CHOP. This could be explained by 
earlier reports suggesting that ATF4 alone is not sufficient for CHOP expression (132) 
(133). Our findings reinforce the idea that additional UPR signals other than those 
transmitted by the PERK- eIF2α – ATF4 branch are required for CHOP induction in 
response to ER stress. 
 
 The exact molecular mechanisms driving sensitizer-induced DC maturation were 
not completely known, however innumerous studies evidence the activation of mitogen-
activated protein kinases (MAPKs) as a crucial event (49, 75). MAPKs participate in a 
diversity of cell processes by controlling transcriptional or translational regulation. ERKs 
have a central role in survival and mitogenic signaling, while JNKs and p38 MAP kinases 
are preferentially activated by environmental stresses and are actively involved in various 
stress responses including cell death, survival and differentiation (75). Given that ER stress 
effector proteins such as IRE1α were shown to crosstalk with MAPKs, particularly JNK 
(51), we analyzed the existence of a possible link between DNFB-induced phosphorylation 
of eIF2α and MAPKs. In accordance to previous studies we observed that DNFB rapidly 
triggers p38 and JNK signaling pathways and that this activation is dependent on 
sensitizer-induced oxidative stress (120, 134). 
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 The inhibition of p38 kinase activity and of JNK 1/2 phosphorylation with 
pharmacological inhibitors was accompanied by a slight decrease in the levels of p-eIF2α. 
This result suggests the possible existence of a link between DNFB-induced MAPK 
activation and the phosphorylation of eIF2α.  Supporting this notion of crosstalk, Liang SH 
and collaborators reported that PERK (the eIF2alpha kinase) is required to activate JNK 
and p38 MAPK and induce the expression of immediate-early genes upon disruption of ER 
calcium homoeostasis (135). 
 
The ER stress response may be viewed as a mechanism to protect the cells from 
different alterations affecting this organelle. However, when the intensity and/or duration 
of the damage do not allows an efficient recovery, ER stress results into cell death. 
Similarly, autophagy can help cells to cope with ER stress, for instance contributing to the 
elimination of unfolded or aggregated proteins or participate in the mechanism of ER 
stress-induced cell death (104). Therefore, we addressed the relevance of the observed 
DNFB-induced eIF2α – ATF4 axis activation in cell cycle, apoptotic and autophagic 
processes. Previous studies showed a connection between ROS production, activation of 
PERK- eIF2α-ATF4 pathway and autophagy (136). In these studies, extracellular matrix 
detachment of mammary epithelial cells resulted in ROS production that activates 
canonical PERK- eIF2α-ATF4 pathway that in turn coordinately induces the autophagy 
regulators ATG6 and ATG8, sustains ATP levels, and reduces redox imbalance.  
 
In our experiments we found that DNFB treatment resulted in a time and 
concentration dependent increase in LC3BII indicating a possible increase in autophagic 
process. However, as autophagy could not be estimated by the singular analysis of LC3B 
we also checked the levels of p62. We found that rather than decrease as expected in 
induced autophagy, p62 levels remained unaltered and seem even to increase in 
concentration-dependent experiments. Although an induction in autophagy could not be 
completely discarded, our results indicate that DNFB mainly causes the blockade of 
autophagic flux.  The impairment of autophagy was recently correlated with the induction 
of a pro-inflammatory response; therefore it is reasonable to speculate that DNFB-induced 
ER-stress could trigger an impairment of the autophagy process and concomitantly activate 
the inflammatory response driven by contact sensitizers. 
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 Regarding the effects in apoptosis we verified that exposure during 24h to 8 µM 
DNFB caused minimal cell death. However, the prevention of DNFB-induced ER stress by 
pre-treatment with the chemical chaperone 4-PBA resulted in a duplication of apoptotic 
cell population. In contrast, a 2 fold reduction was obtained when cells were pre-treated 
with the eIF2α dephosphorylation inhibitor Salubrinal. This indicates that DNFB- 
activation of eIF2α-ATF4 UPR branch is intimately related to cell ability to recovery from 
redox imbalance. Supporting this hypothesis we observed that while 4-PBA caused a 
significant decrease in DNFB-induced transcription of the detoxifying gene HMOX, 
Salubrinal drastically potentiates the increase evoked by the sensitizer.   
 Finally we assessed the eventual relevance of eIF2α-ATF4 axis to DNFB-
induced DC activation/ maturation status. In accordance to previous studies performed in 
other DC models we observed that DNFB causes a significant increase in the transcription 
of the co-stimulatory molecule CD86 and of the pro-inflammatory cytokines IL-1β and IL-
8  (3, 137). As expected, pretreatment of cells with NAC almost completely abrogates 
these effects. The simultaneous exposure of cells to 4-PBA resulted in a slight decrease in 
CD86 and in a drastic decrease of IL-1b transcription, indicating that DNFB-evoked ER 
stress is part of the intricate signaling cascade that drives DC maturation. Surprisingly, 
treatment with Salubrinal and the concomitant sustained activation of the eIF2α-ATF4 axis 
resulted in a dramatic exacerbation of DNFB-induced IL-8 transcription.  As 4-PBA does 
not significantly alter IL-8 mRNA levels evoked by DNFB, we hypothesize that although 
not essential to IL-8 transcription the eIF2α-ATF4 axis may synergize with other 
transcription factor, leading to the observed effect. Overall, our results indicate that DNFB 
activation of eIF2α-ATF4 stress pathway in DC is crucial to the remediation of cell redox 
imbalance through transcriptional control of detoxifying genes and strongly contributes to 
the generation of a pro-inflammatory microenvironment. 
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VII. General conclusions 
 
Overall, we concluded: 
- DNFB induced intense and early ROS production; 
- DNFB does not trigger a canonical ER stress response in contrast to Tunicamycin,  
inducing only p-eIF2a-ATF4 UPR branch; 
- MAPK activation by DNFB probably crosstalk with p-eIF2a;Activation of p-eIF2α – 
ATF4 axis exerts strong cytoprotective effects through exacerbation of detoxifying 
gene transcription;  
- DNFB-evoked ER stress is part of the intricate signaling cascade that drives DC 
maturation; 
- Activation of p-eIF2α – ATF4 axis contributes to the generation of a proinflammatory 
microenvironment.  
 
 
 
  
Future work 
 
- Evaluation of other kinases that also activate the p-eIF2α such as double-stranded 
RNA-activated protein kinase (PKR; activated in viral responses), general control non 
derepressible 2 (GCN2; activated upon aminoacid starvation) and heme-regulated 
inhibitor (HRI; activated in heme depletion);  
- Evaluation of the effects of p-eIF2α – ATF4 axis activation in DNFB-induced 
apoptosis by a more direct technique;  
- -evaluation whether the impairment of autophagy is dependent on p-eIF2α – ATF4 axis 
activation and contributes to the inflammatory response triggered by DNFB;  
- Assessment of the effects of p-eIF2α – ATF4 axis activation in DNFB-induced gene 
transcription of other detoxifying genes: NQO1, TRX, TRXR; 
- Evaluation of the possible synergizing effects with keap-NRF2 pathway.  
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